Next Article in Journal
Structural Insights into HLA-DQ–Associated Susceptibility to Celiac Disease Through an Integrated Genetic and In Silico Approach in a Sardinian Population
Previous Article in Journal
PRSSLY-Based Molecular Sex Determination of Syrian Hamster (Mesocricetus auratus) Pups Using Placental Tissues
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Driven by Dopamine: Genetic Insights into Motivation and Performance in Sports and Esports

by
Natalia Majchrzak
1,
Kinga Humińska-Lisowska
2 and
Agata Leońska-Duniec
2,*
1
Doctoral School, Faculty of Physical Education, Gdansk University of Physical Education and Sport, 80-336 Gdansk, Poland
2
Faculty of Physical Education, Gdansk University of Physical Education and Sport, 80-336 Gdansk, Poland
*
Author to whom correspondence should be addressed.
Genes 2026, 17(2), 144; https://doi.org/10.3390/genes17020144
Submission received: 29 December 2025 / Revised: 19 January 2026 / Accepted: 26 January 2026 / Published: 28 January 2026
(This article belongs to the Section Molecular Genetics and Genomics)

Abstract

Background/Objectives: The dopaminergic system regulates motivation, executive functions, motor learning, and emotional responses—processes that are key in both sport and esports. Although many studies analyse dopaminergic gene polymorphisms, their impact on psychophysical predispositions remains unclear. This narrative review aims to summarise current knowledge about the mechanisms of dopamine action and genetic determinants that may influence athletic and cognitive performance. Methods: The PubMed, Scopus, and Web of Science databases (publications from January 2010 to December 2025) were searched using keywords related to the DRD1–DRD5, COMT, SLC6A3/DAT1, and TH genes, as well as the terms ‘sport’ and ‘esport.’ Studies of athletes were included in which the relationship between dopaminergic polymorphisms and motivational and personality traits was assessed, and the results of neuroimaging and epigenetic studies were also considered. Results: Dopaminergic polymorphisms are associated with differences in reward processing, cognitive flexibility, motivation, and stress resilience. The most essential critical effects concern the DRD2 and DRD4 variants, which are associated with novelty seeking, reward dependence, and coping with stress. The COMT Val158Met polymorphism affects dopamine levels in the prefrontal cortex, modulating executive functions. The effects of individual polymorphisms are moderate, and conclusions regarding esports remain speculative due to limited research in this area. Conclusions: Dopaminergic predispositions involve interactions among genetics, neural activity, and the environment. However, current evidence is limited by small sample sizes, a predominance of European populations, scarce data on esports players, and difficulties in separating genetic effects from training-related adaptations.

1. Introduction

Since Galton’s time (1875), twin studies have become a fundamental approach for analysing the contributions of genetic and environmental factors, with study design expanding to include both monozygotic and dizygotic twins, as well as multigenerational and adoptive families. Early twin studies indicated a significant influence of genetics on behaviour but did not allow for the identification of specific genetic variants. Only later approaches, integrating epigenetics and gene-environment interactions, demonstrated that even monozygotic twins differ in methylation patterns and gene expression, considerably broadening the interpretation of classical twin studies [1,2]; interpretations based solely on early twin designs were, therefore, partly limited and prone to systematic error.
Developments in molecular biology and functional genetics have enabled more precise investigation of specific gene variants, including those related to the dopaminergic system, which plays a central role in the regulation of cognitive, motivational, and emotional functions. These mechanisms are particularly important in the context of sport, including traditional disciplines: intense physical exertion and training are associated with increased dopaminergic activity and improvements in cognitive flexibility, learning speed, and tactical adaptation in athletes [3]. This review adopts a conceptual framework in which dopaminergic gene variability is proposed to partly modulate neural signalling, contributing to inter-individual differences in motivational and personality traits (e.g., novelty seeking and stress resilience). These genetic factors are recognised as influencing behaviours related to performance in sport and esports, as part of a broader, multifactorial system that also includes training conditions and experience. In esports, increasingly seen as an activity requiring high mental and physical fitness, digital competition involves complex processes such as selective and divided attention, reaction speed, and emotional control under time pressure [4,5]. Furthermore, meta-analyses indicate that regular play of action games can lead to improved stimulus processing, working memory, and cognitive flexibility [6,7,8,9]. However, direct genetic evidence in esports remains scarce, and most current hypotheses are extrapolated from studies conducted in traditional sports or related cognitive domains. This raises the fundamental question of whether dopaminergic gene polymorphisms, associated with motivation, stress resilience, and executive function in athletes, may also be relevant for performance in esports players.
The aim of this review is therefore to present the current state of knowledge on the genes of the dopaminergic system and their potential links to psychophysical predispositions in both athletes and participants in digital competition. This study refers to a narrative review, which emphasises the importance of integrating genetic and epigenetic research in sport and esports [3]. Based on available empirical evidence, this review discusses the mechanisms of dopamine action, receptor function, and the role of selected genetic polymorphisms in shaping traits relevant to physical performance, cognitive ability, and psychological adaptation to stress.

2. Materials and Methods: Narrative Review Design

This review was narrative in nature, which distinguishes it from a systematic review primarily in terms of the flexibility of literature selection and data interpretation. As Sukhera notes, narrative reviews allow for the synthesis of studies employing diverse methodologies and provide a critical analysis of the current state of knowledge, with their main value lying in the integration of multiple perspectives [10]. For this reason, despite the lack of a formal protocol registration, the review followed predefined eligibility criteria and transparent procedures for literature identification, selection, and synthesis, with an emphasis on methodological rigour.
The following electronic databases were searched: PubMed, Scopus, and Web of Science. Following the example of studies on the genetic determinants of aerobic capacity [11], a broad time frame was applied, covering publications from 1 January 2010 to 31 December 2025. Selected seminal studies published before 2010 were additionally included to provide essential theoretical and neurobiological background on dopaminergic signalling mechanisms; however, these works were not part of the primary literature screening and were cited solely to support conceptual frameworks and well-established biological principles. No conclusions regarding sport or esports-related genetic associations were drawn exclusively from studies published before 2010. The inclusion and exclusion criteria, as well as the time frame of the literature search, were defined before the screening process was initiated.
The literature search employed combinations of keywords related to dopaminergic genes (e.g., “DRD1”, “DRD2”, “DRD3”, “DRD4”, “DRD5”, “COMT”, “SLC6A3/DAT1”, “tyrosine hydroxylase”) and terms describing performance domains (“sport”, “athletics”, “esports”), psychological constructs (“motivation”, “cognitive function”, “executive functions”, “reward processing”), as well as “polymorphism”, “SNP”, “gene polymorphism” and “epigenetics”. Keywords were combined using AND/OR operators.
Original articles, reviews and meta-analyses meeting the following criteria were included: (1) the study involved humans; (2) the relationship between dopaminergic gene polymorphisms and sports performance, personality traits, motivation, executive functions or training adaptation was analysed; (3) the participants were amateur or professional athletes, or possibly esports players; (4) the article was published in a peer-reviewed scientific journal in English. Due to the limited number of available studies, studies involving non-athletes were also included, provided that the results referred to psychological traits relevant to sport. Studies using only animal models, case reports, letters to the editor, conference abstracts, and articles without full text in English were excluded. In cases where the abstract was in another language, machine translations were used for preliminary assessment, and the final decision was made after analysing the full text.
The selection process was multi-stage. In the first stage, two independent authors reviewed the titles and abstracts of the identified articles, eliminating those that were clearly unrelated to the topic. Publications whose nature was unclear were referred for full-text analysis. Discrepancies in qualification were resolved through discussion; if necessary, a third reviewer was included to reduce bias and increase the reliability of the selection. Information on sample size, gender, age, and ethnicity of participants, type of sport, analysed polymorphisms, psychometric tools, and results was extracted from each article. Data on study design (cross-sectional, cohort, case–control), genotyping methods, and statistical analyses were also included. When contradictory findings were identified, their interpretation considered sample size, population characteristics, replication status, and overall methodological quality. Greater weight was given to findings supported by independent replication or derived from larger and methodologically robust cohorts.
The quality of individual studies was assessed using a modified scale proposed by Hennis et al. and Clark and Baudouin, which was adapted in the review by Bıçakçı et al. [11]. This scale takes into account, among other things, the size and nature of the control group, compliance with Hardy–Weinberg equilibrium, clarity of case group definitions, details of primers used, repeatability of genotyping, blinding of analysts, statistical power calculations, and the validity of analytical methods used. Only studies that met the minimum quality requirements were discussed in detail; in the case of serious methodological shortcomings, the results were interpreted cautiously or excluded from detailed discussion.
The final synthesis was qualitative in nature. Due to the heterogeneity of the measurements used (different psychological tests, various sports disciplines, diverse populations), no meta-analysis was performed. The results were presented in a descriptive form, comparing the effects of individual polymorphisms on psychological traits and sports performance, and identifying recurring patterns and research gaps. Where possible, potential gene-environment interactions, epigenetic mechanisms of gene expression regulation, and neuroimaging results were indicated. This review follows the tradition of narrative reviews, which, although less structured than systematic reviews, allow for a comprehensive analysis and interpretation of complex issues [10], offering the reader an in-depth insight into the role of the dopaminergic system in sports and esports.

3. The Dopaminergic System and Its Biological Significance

Dopamine has a number of functions in the brain beyond traditional motor control. Its activity operates in two complementary modes, tonic (baseline) and phasic (burst-like), and plays a central role in the regulation of motor, motivational, and cognitive processes. In general terms, dopaminergic neurons encode information related to reward and behavioural relevance of stimuli, thereby supporting learning, attention, and adaptive behaviour in changing environmental conditions [12,13,14,15,16].
In contrast, dopamine also contributes to motor learning by modulating neural activity involved in the acquisition and refinement of motor patterns. Experimental and neuroimaging studies suggest that dopaminergic signalling supports the adaptation and stabilization of motor behaviour, through its influence on synaptic plasticity, although in humans these effects appear moderate and show limited replicability, partly due to methodological heterogeneity and reliance on animal models [15,17,18].
Another important aspect of dopamine’s action is its involvement in cognitive processes, especially in the regulation of executive functions such as working memory, attentional control, planning and cost–benefit-based decision-making [19]. Dopaminergic activity within the prefrontal cortex, particularly along the mesocorticolimbic pathway, plays a key role in modulating these functions and supporting flexible, goal-directed behaviour [20]. Alterations in dopaminergic signalling, either insufficient or excessive, are associated with suboptimal cognitive performance, highlighting the importance of balanced dopamine regulation for executive functioning [18].
The topography of dopamine action in the brain is based on the functioning of four major dopaminergic pathways: nigrostriatal, mesolimbic, mesocortical, and tuberoinfundibular. Although their anatomical pathways have been well described, the functional specificity of each pathway continues to raise research questions, especially in the context of complex motor, cognitive, and emotional behaviour. The nigrostriatal pathway, running from the substantia nigra (SN) to the striatum, plays a crucial role in motor control, particularly in the initiation and smooth switching of motor sequences. Degeneration of neurons within this pathway leads to the classic symptoms of Parkinson’s disease, such as bradykinesia, resting tremor or muscle rigidity, as confirmed by both neuropathological and neurochemical studies [21,22]. In the context of sport and esports, the integrity of this pathway may be important not only for movement precision and reaction speed, but also for the inhibition of motor automatisms under dynamic task conditions; however, empirical data in non-clinical populations remain limited and require further well-controlled studies.
The mesolimbic pathway, involving projections from the ventral tegmental area (VTA) to the nucleus accumbens, is primarily responsible for reward processing and motivation. Its activation supports reinforcement-based learning, the subjective experience of pleasure, and the consolidation of goal-directed behaviour [23]. At the same time, dysregulation of this pathway has been linked to pathological motivation states, such as addiction, as well as to anhedonia and depressive symptoms, although effect sizes and replicability remain limited and strongly influenced by individual genetic and environmental variability [24,25].
Also, the mesocortical pathway, which exits the VTA and projects to the prefrontal cortex, is involved in the regulation of executive functions including planning, cognitive control, and working memory. Dopaminergic modulation within this pathway supports flexible cognitive performance, although neuroimaging and pharmacological studies suggest that these effects are of moderate magnitude and are strongly modulated by individual differences in dopaminergic gene polymorphisms, limiting the consistency of findings across studies [18,26]. Alterations in mesocortical dopaminergic signalling have been described in neuropsychiatric conditions such as attention deficit hyperactivity disorder and schizophrenia, although the phenotypic heterogeneity of these disorders complicates the isolation of specific dopaminergic mechanisms.
The tuberoinfundibular pathway regulates prolactin secretion and appears to have marginal relevance for sport and esports performance [27]. While its physiological role is well established, its potential influence on cognitive or behavioural function, particularly in the context of long-term pharmacological modulation, remains insufficiently explored.
Each of these pathways is characterized by a distinct neuroanatomical architecture, specific receptor distributions, and unique regulatory mechanisms. This complexity allows dopamine to simultaneously support motor, cognitive, emotional, and endocrine functions. Understanding the interactions between these pathways and their individual modulation opens new perspectives in the study of human psychophysical functioning and in the analysis of an individual’s predisposition, both in the context of health and performance in sport and esports.
Dopamine receptors comprise five subtypes (D1–D5) that belong to the family of metabotropic G protein-coupled receptors and are functionally divided into two main classes. D1-type receptors (D1 and D5), coupled to Gs proteins, stimulate adenylate cyclase activity and increase cyclic adenosine monophosphate (cAMP) levels in cells, while D2-type receptors (D2, D3, and D4), coupled to Gi/o proteins, inhibit adenylate cyclase and decrease cAMP production. These classes of receptors are widely distributed across brain regions such as the prefrontal cortex, striatum, and hippocampus, where they modulate neuronal excitability, synaptic plasticity, and cognitive functions, including executive control and working memory [28]. Functional differences between D1- and D2-type receptors contribute to the regulation of attentional stability, motivational salience, and behavioural flexibility [20,29]. The main distribution and signalling properties of D1–D5 receptors are summarised in Figure 1.
Although dopamine receptor subtypes that operate in distinct neuroanatomical and functional contexts, their combined action enables a fine-tuned modulation of reward-related behaviour and cognition, strongly dependent on environmental context and interactions with other neurotransmitter systems. Their detailed location and functional characteristics are shown in Table 1 [28,30].
Dopamine is a key integrator of motor, cognitive, emotional, and endocrine functions, acting through diverse pathways and receptors distributed throughout the brain. The heterogeneity of its receptors—both in terms of structure and location—allows neuronal responses to be fine-tuned to changing environmental conditions and the body’s internal needs [31]. Understanding the function of individual dopaminergic proteins not only deepens our understanding of the neurobiology of behaviour but also opens new research opportunities for optimising performance in sport, esports, and everyday cognitive functioning. Figure 2 presents a conceptual overview integrating dopaminergic genetic factors, major neural pathways, epigenetic mechanisms, and environmental influences in relation to sports and esports performance.

4. Genes and Polymorphisms of the Dopaminergic System

The previous chapter described the molecular structure and distribution of dopamine receptors (D1–D5), while this section discusses the best-known polymorphisms in the genes encoding these receptors and, in the genes involved in dopamine synthesis, degradation, and transport. These variants are among the most frequently studied factors influencing individual differences in cognitive, motivational, and emotional functions, as well as susceptibility to various neuropsychiatric disorders [32].
Among the genes encoding receptors, DRD2 and the dopamine D4 receptor gene (DRD4) are particularly noteworthy, as their functional variability is important for dopaminergic transmission. The DRD2 gene encodes the D2 receptor, a key regulator of dopaminergic transmission in the striatum and prefrontal cortex. Polymorphisms such as rs1800497 and rs1076560 affect dopaminergic signalling and receptor availability [28,33,34]. The rs1800497 polymorphism, located in the neighbouring ankyrin repeat and kinase domain containing 1 gene (ANKK1) but linked to DRD2, has been associated with reduced D2 receptor availability and altered dopaminergic tone [34,35]. Allele A1 (T) correlates with lower D2 receptor binding potential in the striatum in healthy individuals, suggesting its influence on receptor density and dopamine feedback mechanisms [35]. However, the effects of this variant depend on the environmental and physiological context, including behavioural factors, which may explain the ambiguity of the research results [36].
Another frequently analysed variant, rs1076560, has been linked to differences in dopaminergic signalling and neural activation during cognitive tasks, although reported effects vary across studies and populations [37]. These findings emphasise that receptor polymorphisms rarely act in isolation and that their behavioural consequences depend on interactions with the environment, task demands and individual neurochemical background [26,38]. Overall, DRD2 polymorphisms illustrate how dopaminergic genetic variants exert subtle, context-dependent effects rather than deterministic influences on behaviour. It is worth noting that a study published in the Baltic Journal of Health and Physical Activity, compared athletes and non-athletes and reported a higher prevalence of the Taq1D rs1800498 (DRD2) variant among athletes. Carriers of this variant also scored higher on the NEO Five Factor Inventory (NEO-FFI) extroversion and conscientiousness scales, suggesting that this polymorphism may be associated with personality traits beneficial to athletic performance [39].
The second gene of great research significance is DRD4, characterised by high allelic variability. The most frequently analysed variant is the 48 bp variable number tandem repeats (VNTR) in exon 3, which leads to the formation of receptor isoforms differing in the number of tandem repeats, most often 4-repeat (4R) and 7-repeat (7R) [40]. The 7R allele has been associated with reduced sensitivity to dopamine and altered intracellular signalling, which may influence behavioural plasticity and responsiveness to rewarding stimuli [41,42]. Carriers of this allele tend to show higher levels of novelty seeking and exploratory behaviour, although these effects are strongly modulated by environmental factors such as upbringing and stress in early life [43,44]. Consequently, the behavioural impact of the DRD4 VNTR appears to be context-dependent, with the same variant potentially supporting either adaptive flexibility or risk-prone behaviour depending on environmental conditions. Another polymorphism of this gene, rs1800955, located in the promoter region, has been associated with differences in transcriptional activity and personality traits, although findings across studies remain inconsistent [45,46]. For example, research conducted in elite martial artists indicated associations between DRD4 VNTR genotypes and selected NEO-FFI personality dimensions, but these effects varied across traits, and genotypic groups [47]. This pattern makes DRD4 particularly relevant for disciplines requiring rapid adaptation and exploratory behaviour [48], although evidence in esports remains largely indirect. Overall, DRD2 and DRD4 illustrate the multigenic and context-dependent nature of dopaminergic modulation—individual variants have subtle but measurable effects on cognition and behaviour, which may be amplified in interaction with environmental or developmental factors. The most frequently studied polymorphisms of dopamine D1–D5 receptor genes (DRD1–DRD5), their location, and possible mechanisms of action are presented in Table 2.
In addition to receptor variability, dopamine levels also depend on genes involved in the synthesis, degradation, and transport of the neurotransmitter. The best known of these are catechol-O-methyltransferase (COMT), Solute Carrier Family 6 Member 3 (SLC6A3) (also known as DAT1) and TH [69,70,71]. The COMT gene, located on chromosome 22q11.21, encodes the enzyme catechol-O-methyltransferase, which is responsible for the degradation of catecholamines, including dopamine, in the prefrontal cortex. The functional polymorphism rs4680 results in a valine-to-methionine substitution (Val158Met) results in amino acid change that leads to reduce enzyme’s activity and consequently higher dopamine availability in the prefrontal cortex [72,73,74]. The Met allele has been associated with better performance in tasks requiring working memory and executive functions, as well as with inter individual differences in emotional and behavioural disorders [18,20]. Humińska-Lisowska et al. [75] analysed combat sports athletes and control subjects and demonstrated that the distribution of Val158Met genotypes differed between groups, and that the COMT genotype significantly interacted with personality traits such as novelty seeking, self-control, and self-transcendence [75]. These observations are consistent with the notion that balanced dopaminergic signalling in the prefrontal cortex is critical for optimal cognitive functioning.
The SLC6A3 gene, located on chromosome 5p15.33, encodes the dopamine transporter (DAT), which is responsible for its reuptake and maintaining extracellular concentration balance. The most studied polymorphism is the 40 bp VNTR in the 3′ UTR region, where the 9-repeat (9R) and 10-repeat (10R) alleles are dominant. The 9R allele is associated with lower transporter expression and higher dopamine levels in the synaptic space, while 10R is associated with greater DAT affinity and more effective reuptake [76]. Neuroimaging and behavioural studies suggest that these variants influence reward sensitivity, attentional control, and impulsivity, although results remain heterogeneous across populations [77].
Another important element in dopamine synthesis is the TH gene, located on chromosome 11p15.5, which encodes tyrosine hydroxylase, an enzyme that limits the rate of conversion of tyrosine to L-3,4-dihydroxyphenylalanine (L-DOPA). Variability in the TH promoter region (e.g., rs10770141) can modulate transcriptional activity and the rate of dopamine production, and some studies link this polymorphism to differences in temperament traits and cognitive functioning in individuals with mental disorders [78,79]. Although less frequently studied than dopamine receptor genes or the SLC6A3 transporter, TH variants may contribute to individual differences in baseline dopaminergic tone, particularly in interaction with stress or other genetic factors [80,81].
The collected data indicate that polymorphisms within dopaminergic genes act as subtle modulators rather than clear determinants of behaviour or cognitive functions. DRD2 and DRD4 variants influence receptor expression and sensitivity, while polymorphisms in COMT, SLC6A3, and TH regulate dopamine availability through metabolic and transport mechanisms. The combined effect of these genes shapes individual differences in motivation, cognitive flexibility, and emotion regulation. The most important polymorphisms of genes associated with dopamine metabolism and transport, their potential biological effects, and the research context are summarised in Table 3.
However, the functional effects of dopaminergic polymorphisms are strongly dependent on the environmental context. Stress, learning experiences and developmental conditions can modify the relationship between genotype and neural function efficiency, contributing to substantial inter-individual variability [14,91]. This dynamic interaction between genetic background and environmental factors help explain why the same variants may lead to different phenotypic outcomes across studies and supports the view that a multigene, network model of dopaminergic regulation is more appropriate than a ‘single gene’ approach.

5. Epigenetic Modulation of the Dopaminergic System in Athletes

There is increasing evidence suggesting that the variability of dopamine-dependent phenotypes is shaped not only by DNA sequence, but also by epigenetic mechanisms. This group includes DNA methylation, histone modifications, and the expression of non-coding RNAs, which regulate transcription without interfering with the nucleotide sequence itself. At the systemic level, regular physical activity and training loads generate reactive oxygen and nitrogen species, initiating changes in DNA methylation patterns and other epigenome modifications [92]. Reviews indicate that the response to a training programme depends on fitness status and that intensive training can be associated with telomere length changes and modulate DNA structure [93]. Methylation responses have been observed to vary depending on workload and sleep quality [94,95].
Epigenetics is also sensitive to psychosocial stress. A neuropsychological study has shown that methylation at the Val158 polymorphism site in the COMT gene is inversely correlated with the number of stressful life events and positively correlated with working memory performance. The results suggest that chronic stress may reduce methylation levels and increase COMT expression, leading to reduced dopamine availability in the prefrontal cortex. Methylation changes may therefore play a potentially compensatory role, possibly influencing the efficiency of executive networks [96].
Direct epigenetic evidence concerning athletes is still scarce, but pioneering studies have emerged in recent years. Humińska-Lisowska et al. analysed DNA methylation within the promoter and first exon of the dopamine transporter gene SLC6A3 (DAT1) in athletes and physically inactive individuals. In athletes, a significantly higher methylation levels compared to controls, and the overall promoter methylation was markedly elevated. Personality assessment using the NEO-FFI questionnaire indicated that athletes scored higher on Extraversion and Conscientiousness, and promoter methylation levels were positively associated with selected personality traits. These findings suggest that increased methylation within the SLC6A3 promoter region may be associated with training-related adaptations and may co-occur with personality characteristics conducive to athletic achievement [97].
Another advanced analysis was presented in a study of martial artists. The authors demonstrated that martial artists are characterised by higher methylation in the promoter region of SLC6A3 and lower impulsivity than non-athletes. A significant interaction between the VNTR genotype and methylation was also found, even though allele frequencies did not differ between groups [98]. These results suggest that intensive training and competitive stress may induce adaptive epigenetic changes over time, confirming the plastic nature of methylation in athletes.
In healthy non-athletes, methylation of dopamine-related gene promoters—including DBH (Dopamine Beta-Hydroxylase), SLC6A3, and DRD2—was associated with performance on a line judgement task, and the combined methylation profile of these three genes explained a significant portion of the variability in attention lateralisation [99]. This means that epigenetic markers may be associated with not only personality traits, but also attention and perception processes.
In summary, epigenetic mechanisms play an important role in modulating dopamine availability in key areas of the brain. Unlike fixed polymorphisms, DNA methylation levels are sensitive to factors such as training loads, psychological stress, sleep, and diet. The integration of methylation measurements—especially in the promoter regions of SLC6A3, COMT, and DRD2—with behavioural assessments, training loads, and stress markers may allow for more precise modelling of psychomotor and motivational predispositions in sport and esport in future, provided that longitudinal designs and adequate control of confounding variables are applied.

6. Significance of Dopaminergic Gene Polymorphisms in the Context of Predisposition to Physical and Esports Activity

Contemporary research on sport and its digital variant, esports, emphasises that the success of competitors is determined by a complex and dynamic interaction of psychological, neurophysiological, and genetic factors [100]. A narrative review of the role of dopamine in sport indicates that, in addition to physical fitness and technical skills, mental resilience and the ability to cope with stress, which are shaped by both innate genetic predispositions and environmental influences, are of key importance. The authors estimate that approximately 66% of the variability in an athlete’s status may be attributed to genetic factors, with the remainder depending on training, diet, and life experiences. The same review emphasised that dopamine, a key neurotransmitter in the brain, regulates behaviour, motivation, learning, and motor control, pointing to a neurophysiological component of athletic success [3]. In addition, a meta-analysis of over 100 studies showed that psychological traits such as motivation, self-efficacy, conscientiousness, and extraversion have significant, albeit moderate, associations with athletic performance [101]. Taken together, these data confirm that performance in sport and esports is the result of a synergy between innate biological conditions and training and life experiences that shape an athlete’s temperament, mental resilience, and neurophysiology.
Esports introduce a separate dimension, which, although lacking a physical component, requires high cognitive skills, quick adaptation, and mental resilience. Research on League of Legends players shows that higher-ranked players are less extroverted and conciliatory, but more open to experiences than their colleagues from lower divisions [102]. Another cross-sectional study involving 416 esports players and 452 traditional athletes showed that esports players are less extroverted and less conscientious, although the number of years spent training in esports correlated positively with extroversion [103]. The authors suggest that the gaming environment may attract people with less need for social contact and lower levels of planning, while success favours those who are more cognitively flexible. The data available to date therefore points to a potentially specific personality profile in esports, different from that of traditional athletes; however, it is not known to what extent this is due to the same neurophysiological and genetic mechanisms that determine success in sport. This research gap becomes the starting point for further analysis in this chapter.
Dopamine is a key neurotransmitter involved in motivation, reward regulation, motor control, and executive functions [104]. In a narrative review on sport, Humińska-Lisowska describes how dopamine is sometimes referred to as the ‘motivation hormone for action and seeking new emotions’; this neurotransmitter affects a wide range of functions, from behaviour and learning to emotions and movement control, and differences in dopaminergic activity may translate into athletic predisposition and training perseverance [3]. At the genetic level, polymorphisms in the DRD gene, COMT, and DAT1 are considered to play an important role. These variants modify receptor density, neurotransmitter degradation rate, and reuptake intensity, which influences individual differences in motivation, reward sensitivity, and stress resilience [3,105].
Most of the data comes from research on the DRD2 gene. In an analysis of 258 men who practised combat sports and 284 non-exercising volunteers, the DRD2 promoter polymorphism (rs1799732; del/ins) did not differ in frequency between the groups, but the interaction between participation in sport and genotype influenced temperament traits. Among athletes, deletion carriers scored lower on the reward dependence scale and higher on the self-direction scale, suggesting that this variant may be associated with greater autonomy and composure. The same group of athletes showed higher levels of self-discipline and cooperation than the control group, although the differences were subtle [106]. Further studies confirm that in karate, judo, boxing, and wrestling athletes, having specific DRD2 alleles may correlate with personality traits such as conscientiousness and extroversion, which may promote regular training [107].
The analyses also focused on the rs6277 polymorphism and the rs1800497 variant associated with DRD2 in individuals with problem gambling. In a study involving 168 students, genotyping showed that the combination of the T allele in rs6277 and the A1 allele in rs1800497, under conditions of high interpersonal stress, was associated with higher levels of problem gambling; this effect was mediated by stress avoidance strategies. The results suggest that the impact of stress on gambling behaviour may depend on genetic variants associated with DRD2 and coping style, and that individuals carrying certain genetic profiles may be more likely to engage in gambling as a coping strategy when faced with social pressure [108]. However, it should be emphasised that the rs1800497 (Taq1A) variant is located in the neighbouring ANKK1 gene, and its effect on the functioning of the dopamine D2 receptor is indirect, reflecting regulatory effects rather than a direct change in the DRD2 coding sequence [109]. Although these studies did not strictly focus on professional esports players, they point to a potential gene-environment mechanism that may influence long-term engagement in video games.
The literature also discusses the involvement of other dopaminergic receptors. DRD3 variants (e.g., rs167771) are associated with higher levels of agreeableness, which may facilitate cooperation in team sports [110], while polymorphisms in DRD4 (e.g., variable number of VNTRs in exon 3) influence novelty seeking and impulsivity, which has been suggested to be associated with success in extreme sports [47]. However, these studies often have small sample sizes and are limited to selected disciplines, which makes it difficult to generalise the results. The DRD1 and DRD5 genes, which activate adenylate cyclase and increase cAMP production, have been studied less frequently, and a large Swedish cohort found only a slight correlation between the DRD1 rs4532 variant and the level of moderate and intense physical activity in older people—CC genotype carriers were more active than T allele carriers [111].
In the context of dopamine-metabolising enzymes, particular importance is attached to the Val158Met (rs4680) polymorphism in the COMT gene, which affects the activity of the catechol-O-methyltransferase enzyme and dopamine concentration in the prefrontal cortex [112]. Studies of athletes suggest that carriers of the Met (A) allele are more resistant to stress and perform better in cognitive flexibility tests, although the results are inconsistent [113]. Polymorphisms in the DAT1 transporter, especially the VNTR in the 3′ region, modulate the rate of dopamine reuptake; however, a large study of 8768 adults found no significant correlation between these variants and weekly exercise time, suggesting that single genetic markers have little predictive value in assessing exercise habits [114].
There is significantly less data available on electronic sports. Research on video game-related disorders indicates that DRD2 polymorphisms may influence susceptibility to problematic gaming, especially in the presence of stress, but there is a lack of research on the population of professional esports players [108]. Neuropsychological data suggest that professional gamers may have a different personality and cognitive profile than athletes; greater openness and cognitive flexibility may compensate for a lower need for sensory stimulation, as reflected in the results of personality studies of gamers [115]. Potential studies could verify whether the DRD2, DRD4, or COMT variants play a similar role in shaping motivation and playing style in esports players as they do in traditional athletes.
To summarise the issues discussed so far and to highlight selected dopaminergic polymorphisms analysed in the context of psychological and sporting predispositions—their location, functional significance, and potential impact on behaviours relevant to esports (Table 4).
In summary, current evidence suggests that dopaminergic polymorphisms have a moderate, context-dependent influence on personality traits and behaviours related to sporting activity. In traditional sports, certain variants of DRD2 and DRD4 may promote motivation to train and perseverance, while others (DRD3, COMT) may enhance cooperation and mental resilience. In esports, where motivation and reward are different in nature, genetic-environmental interactions require further analysis. In the future, the integration of genetic research with the assessment of psychological and environmental traits may contribute to the development of more precise research frameworks, rather than direct performance prediction.

7. Conclusions and Further Research Direction

The accumulated literature suggests the importance of the dopaminergic system as an axis integrating cognitive, emotional, and motor components in the context of athletic performance. Nevertheless, the current state of knowledge reveals significant gaps that limit the possibility of formulating a coherent model of neurogenetic predispositions to psychophysical performance. Despite the growing number of studies analysing individual polymorphisms within genes such as DRD2, DRD4, COMT and SLC6A3, the vast majority of available data is based on correlational analyses conducted in isolation from other levels of biological organisation, such as neuronal activity or personality structure [3,124].
One of the main methodological barriers remains the lack of studies integrating genotype data with functional neuroimaging results and detailed assessments of temperament and personality traits. Existing approaches rarely consider the interactions between the neurobiological profile and the psychological construct, leading to fragmented knowledge and difficulties in interpreting the functional implications of specific genetic variants [125]. In particular, there is a lack of studies linking the presence of specific alleles to dopaminergic system activity measured by functional magnetic resonance imaging (fMRI), positron emission tomography (PET), or electroencephalography (EEG), and simultaneous measurement of stable temperamental traits in a biological-psychological model. This type of data triangulation could contribute to more nuanced explanatory models that take into account both innate traits and neuroplasticity dynamically shaped by the environment [126]. Recent empirical work has demonstrated the value of integrative approaches, showing that polygenic co-expression indices combined with PET imaging may better reflect dopamine synthesis capacity than single nucleotide polymorphism (SNP) analyses [127], while cumulative genetic indicators integrated with EEG measurements reveal task-demand interactions that escape the detection of single polymorphism studies [128]. These findings underscore the need to move from reductionist models to comprehensive frameworks that account for the complexity of gene-brain-behaviour relationships in sporting contexts. Most existing studies have focused on single polymorphisms or a limited number of SNPs, despite the polygenic nature of motivation, cognitive performance, and behavioral traits. Future research should therefore incorporate a broader range of genetic variants to allow the investigation of cumulative and interactive effects. In addition, many studies to date have relied on relatively small samples, predominantly of European ancestry, with women often underrepresented. Given the importance of population background in genetic association studies, future research should include larger, more diverse cohorts across different ancestries and sexes. Taken together, these limitations highlight the early and heterogeneous nature of the field and the need for more robust, integrative, and well-powered studies.
The second key area requiring intensified research is epigenetics, which offers the potential to explain phenotypic variability that is not captured in purely genotypic models. As noted in a narrative review by Humińska-Lisowska, combining genetic and epigenetic data is a key direction in research on the psychomotor predispositions of athletes [3]. While physical exercise and training induce extensive epigenomic changes in human skeletal muscle and blood, including alterations in DNA methylation patterns, histone modifications, and non-coding RNA expression [129,130]. There is a lack of in-depth analyses covering dopaminergic genes and the biochemical pathways involved in their expression. Recent whole-genome methylation studies in athletes have documented training-induced epigenetic remodelling in multiple physiological systems [131,132], and mechanistic reviews linked redox signalling to changes in DNA methylation during adaptation to exercise [92]. However, direct evidence for epigenetic regulation of SLC6A3, DRD2, COMT or other dopaminergic genes in athletic populations is still insufficient. This issue is particularly important in the context of environments that chronically expose individuals to stress, such as elite sport or esports competition, which are known to modulate gene activity through permanent epigenetic changes without interfering with the nucleotide sequence [93]. Emerging evidence from neuroscience shows that physical exercise can restore methylation-dependent mechanisms in stress-related brain regions and increase behavioural resilience [133], suggesting that the dopaminergic system could potentially be similarly modulated through epigenetic pathways during sports training and competition. Future studies should therefore include measurement of DNA methylation patterns, histone modifications, and microRNA expression within the dopaminergic axis, considering variables such as duration of stress exposure, training intensity, and sleep quality.
Finally, it is important to highlight the clear lack of research focusing on the population of esports players, whose workload is primarily cognitive and affective rather than somatic. Most genetic analyses are conducted in the context of traditional sports, limiting the ability to extrapolate the results to the digital competitive environment. Meanwhile, esports offer a unique opportunity to study the impact of dopaminergic processing on cognitive functions under conditions of high pace, time pressure, and decision-making complexity [134,135]. The latest meta-analysis data confirms that esports expertise is associated with measurable cognitive advantages, particularly in the domains of spatial cognition and attention [136], and empirical studies have linked cognitive flexibility and decision-making performance to ranking in multiplayer battle arena games [137]. Furthermore, emotional regulation and managing frustration-induced performance deterioration (tilt) are critical psychological competencies in esports that may be modulated by dopaminergic function [138,139]. Prolonged esports sessions induce objective cognitive fatigue with clear neurophysiological signatures, including pupil constriction and decreased executive function, which do not correlate with subjective reports of fatigue [140], pointing to complex interactions between dopaminergic tone, cognitive demands, and performance consistency. Despite these insights into the neurocognitive architecture of esports performance, there is currently lack of research systematically verifying the relationship between dopaminergic gene variants and measures of cognitive performance, attentional control, and emotional regulation in this population. Given that dopamine synthesis capacity predicts cognitive effort allocation and decision-making errors in demanding conditions [141,142], and functional connectivity within dopaminergic networks supports rapid attention switching and sensorimotor decisions in gamers [143], the study of genetic predispositions in esports represents a critical frontier for understanding the neurobiological basis of digital competition.
In summary, future research should move beyond one-dimensional models of single polymorphisms towards an integrative approach combining genetic, epigenetic, neurophysiological, and psychometric data [66]. In this field, multimodal datasets comprising polygenic or co-expression indices should be used instead of isolated SNPs, combine PET and fMRI with rigorous assessment of temperament and personality, use sufficiently large samples to enable replication, and support multidisciplinary teams with standardised protocols to reduce heterogeneity and improve mechanistic inference [128,144]. Only such a multidisciplinary perspective will bring us closer to a holistic understanding of the neurobiological basis of psychophysical performance, both in classical sports and in contemporary forms of digital competition. The convergence of molecular genetics, functional neuroimaging, epigenomics and psychological sciences may change our understanding of individual differences in athletic and cognitive performance, which may ultimately inform future research on talent development, training optimisation and individual differences in performance.

Author Contributions

Conceptualization, N.M.; writing—original draft preparation, N.M.; writing—review and editing, N.M., A.L.-D. and K.H.-L.; supervision, A.L.-D. and K.H.-L. All authors have read and agreed to the published version of the manuscript.

Funding

Financially supported by Minister of Science under the ‘Regional Initiative of Excellence’ programme.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

No new data were created or analyzed in this study. Data sharing is not applicable to this article.

Conflicts of Interest

The author declares no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
10R10-repeat
4R4-repeat
7R7-repeat
9R9-repeat
ADHDAttention Deficit Hyperactivity Disorder
ANKK1Ankyrin repeat and kinase domain containing 1
cAMPCyclic Adenosine Monophosphate
COMTCatechol-O-methyltransferase
D1–D5Dopamine receptor type 1–5
D2LLong isoform of the dopamine D2 receptor
D2SShort isoform of the dopamine D2 receptor
DAT1Dopamine transporter
DBHDopamine Beta-Hydroxylase
DRD1Dopamine D1 receptor gene
DRD2Dopamine D2 receptor gene
DRD3Dopamine D3 receptor gene
DRD4Dopamine D4 receptor gene
DRD5Dopamine D5 receptor gene
EEGElectroencephalography
fMRIFunctional magnetic resonance imaging
L-DOPAL-3,4-dihydroxyphenylalanine
NEO-FFINEO Five Factor Inventory
PETPositron emission tomography
SLC6A3Solute Carrier Family 6 Member 3
SNSubstantia Nigra
SNPSingle Nucleotide Polymorphism
THTyrosine Hydroxylase
Val158MetValine-to-methionine substitution
VNTRVariable Number Tandem Repeats
VTAVentral Tegmental Area

References

  1. Sahu, M.; Prasuna, J. Twin Studies: A Unique Epidemiological Tool. Indian J. Community Med. 2016, 41, 177–182. [Google Scholar] [CrossRef]
  2. Choi, C.Q. How Epigenetics Affects Twins. Genome Biol. 2004, 5, spotlight-20050708-02. [Google Scholar] [CrossRef]
  3. Humińska-Lisowska, K. Dopamine in Sports: A Narrative Review on the Genetic and Epigenetic Factors Shaping Personality and Athletic Performance. Int. J. Mol. Sci. 2024, 25, 11602. [Google Scholar] [CrossRef] [PubMed]
  4. Bavelier, D.; Green, C.S.; Pouget, A.; Schrater, P. Brain Plasticity Through the Life Span: Learning to Learn and Action Video Games. Annu. Rev. Neurosci. 2012, 35, 391–416. [Google Scholar] [CrossRef]
  5. Granic, I.; Lobel, A.; Engels, R.C. The Benefits of Playing Video Games. Am. Psychol. 2014, 69, 66–78. [Google Scholar] [CrossRef] [PubMed]
  6. Feng, J.; Spence, I. Playing Action Video Games Boosts Visual Attention. In Video Game Influences on Aggression, Cognition, and Attention; Ferguson, C.J., Ed.; Springer International Publishing: Cham, Switzerland, 2018; pp. 93–104. [Google Scholar]
  7. Pallavicini, F.; Ferrari, A.; Mantovani, F. Video Games for Well-Being: A Systematic Review on the Application of Computer Games for Cognitive and Emotional Training in the Adult Population. Front. Psychol. 2018, 9, 2127. [Google Scholar] [CrossRef] [PubMed]
  8. Smith, E.T.; Basak, C. A Game-Factors Approach to Cognitive Benefits from Video-Game Training: A Meta-Analysis. PLoS ONE 2023, 18, e0285925. [Google Scholar] [CrossRef]
  9. Wang, P.; Liu, H.-H.; Zhu, X.-T.; Meng, T.; Li, H.-J.; Zuo, X.-N. Action Video Game Training for Healthy Adults: A Meta-Analytic Study. Front. Psychol. 2016, 7, 907. [Google Scholar] [CrossRef]
  10. Sukhera, J. Narrative Reviews: Flexible, Rigorous, and Practical. J. Grad. Med. Educ. 2022, 14, 414–417. [Google Scholar] [CrossRef]
  11. Bıçakçı, B.; Cięszczyk, P.; Humińska-Lisowska, K. Genetic Determinants of Endurance: A Narrative Review on Elite Athlete Status and Performance. Int. J. Mol. Sci. 2024, 25, 13041. [Google Scholar] [CrossRef]
  12. Schultz, W. Dopamine Reward Prediction-Error Signalling: A Two-Component Response. Nat. Rev. Neurosci. 2016, 17, 183–195. [Google Scholar] [CrossRef]
  13. Holroyd, C.B.; Nieuwenhuis, S.; Yeung, N.; Cohen, J.D. Errors in Reward Prediction Are Reflected in the Event-Related Brain Potential. NeuroReport 2003, 14, 2481–2484. [Google Scholar] [CrossRef]
  14. Matsumoto, M.; Hikosaka, O. Two Types of Dopamine Neuron Distinctly Convey Positive and Negative Motivational Signals. Nature 2009, 459, 837–841. [Google Scholar] [CrossRef]
  15. Molina-Luna, K.; Pekanovic, A.; Röhrich, S.; Hertler, B.; Schubring-Giese, M.; Rioult-Pedotti, M.-S.; Luft, A.R. Dopamine in Motor Cortex Is Necessary for Skill Learning and Synaptic Plasticity. PLoS ONE 2009, 4, e7082. [Google Scholar] [CrossRef]
  16. Brown, M.T.C.; Henny, P.; Bolam, J.P.; Magill, P.J. Activity of Neurochemically Heterogeneous Dopaminergic Neurons in the Substantia Nigra during Spontaneous and Driven Changes in Brain State. J. Neurosci. 2009, 29, 2915–2925. [Google Scholar] [CrossRef]
  17. Cousineau, J.; Plateau, V.; Baufreton, J.; Le Bon-Jégo, M. Dopaminergic Modulation of Primary Motor Cortex: From Cellular and Synaptic Mechanisms Underlying Motor Learning to Cognitive Symptoms in Parkinson’s Disease. Neurobiol. Dis. 2022, 167, 105674. [Google Scholar] [CrossRef] [PubMed]
  18. Cools, R.; D’Esposito, M. Inverted-U–Shaped Dopamine Actions on Human Working Memory and Cognitive Control. Biol. Psychiatry 2011, 69, e113–e125. [Google Scholar] [CrossRef] [PubMed]
  19. Muehlberg, C.; Goerg, S.; Rullmann, M.; Hesse, S.; Sabri, O.; Wawrzyniak, M.; Classen, J.; Fricke, C.; Rumpf, J.-J. Motor Learning Is Modulated by Dopamine Availability in the Sensorimotor Putamen. Brain Commun. 2024, 6, fcae409. [Google Scholar] [CrossRef] [PubMed]
  20. Arnsten, A.F.T.; Rubia, K. Neurobiological Circuits Regulating Attention, Cognitive Control, Motivation, and Emotion: Disruptions in Neurodevelopmental Psychiatric Disorders. J. Am. Acad. Child Adolesc. Psychiatry 2012, 51, 356–367. [Google Scholar] [CrossRef]
  21. Hornykiewicz, O. Chemical Neuroanatomy of the Basal Ganglia—Normal and in Parkinson’s Disease. J. Chem. Neuroanat. 2001, 22, 3–12. [Google Scholar] [CrossRef]
  22. Surmeier, D.J.; Obeso, J.A.; Halliday, G.M. Selective Neuronal Vulnerability in Parkinson Disease. Nat. Rev. Neurosci. 2017, 18, 101–113. [Google Scholar] [CrossRef]
  23. Volkow, N.D.; Morales, M. The Brain on Drugs: From Reward to Addiction. Cell 2015, 162, 712–725. [Google Scholar] [CrossRef]
  24. Salamone, J.D.; Yohn, S.E.; López-Cruz, L.; San Miguel, N.; Correa, M. Activational and Effort-Related Aspects of Motivation: Neural Mechanisms and Implications for Psychopathology. Brain 2016, 139, 1325–1347. [Google Scholar] [CrossRef] [PubMed]
  25. Treadway, M.T.; Zald, D.H. Reconsidering Anhedonia in Depression: Lessons from Translational Neuroscience. Neurosci. Biobehav. Rev. 2011, 35, 537–555. [Google Scholar] [CrossRef]
  26. Dang, L.C.; O’Neil, J.P.; Jagust, W.J. Genetic Effects on Behavior Are Mediated by Neurotransmitters and Large-Scale Neural Networks. NeuroImage 2013, 66, 203–214. [Google Scholar] [CrossRef] [PubMed]
  27. Peuskens, J.; Pani, L.; Detraux, J.; De Hert, M. The Effects of Novel and Newly Approved Antipsychotics on Serum Prolactin Levels: A Comprehensive Review. CNS Drugs 2014, 28, 421–453. [Google Scholar] [CrossRef]
  28. Beaulieu, J.-M.; Gainetdinov, R.R. The Physiology, Signaling, and Pharmacology of Dopamine Receptors. Pharmacol. Rev. 2011, 63, 182–217. [Google Scholar] [CrossRef] [PubMed]
  29. Rosen, Z.B.; Cheung, S.; Siegelbaum, S.A. Midbrain Dopamine Neurons Bidirectionally Regulate CA3-CA1 Synaptic Drive. Nat. Neurosci. 2015, 18, 1763–1771. [Google Scholar] [CrossRef]
  30. Missale, C.; Nash, S.R.; Robinson, S.W.; Jaber, M.; Caron, M.G. Dopamine Receptors: From Structure to Function. Physiol. Rev. 1998, 78, 189–225. [Google Scholar] [CrossRef]
  31. Lauretani, F.; Giallauria, F.; Testa, C.; Zinni, C.; Lorenzi, B.; Zucchini, I.; Salvi, M.; Napoli, R.; Maggio, M.G. Dopamine Pharmacodynamics: New Insights. Int. J. Mol. Sci. 2024, 25, 5293. [Google Scholar] [CrossRef]
  32. Nemoda, Z.; Szekely, A.; Sasvari-Szekely, M. Psychopathological Aspects of Dopaminergic Gene Polymorphisms in Adolescence and Young Adulthood. Neurosci. Biobehav. Rev. 2011, 35, 1665–1686. [Google Scholar] [CrossRef] [PubMed]
  33. Bertolino, A.; Taurisano, P.; Pisciotta, N.M.; Blasi, G.; Fazio, L.; Romano, R.; Gelao, B.; Bianco, L.L.; Lozupone, M.; Di Giorgio, A.; et al. Genetically Determined Measures of Striatal D2 Signaling Predict Prefrontal Activity during Working Memory Performance. PLoS ONE 2010, 5, e9348. [Google Scholar] [CrossRef]
  34. Gluskin, B.S.; Mickey, B.J. Genetic Variation and Dopamine D2 Receptor Availability: A Systematic Review and Meta-Analysis of Human in Vivo Molecular Imaging Studies. Transl. Psychiatry 2016, 6, e747. [Google Scholar] [CrossRef]
  35. Savitz, J.; Hodgkinson, C.A.; Martin-Soelch, C.; Shen, P.-H.; Szczepanik, J.; Nugent, A.C.; Herscovitch, P.; Grace, A.A.; Goldman, D.; Drevets, W.C. DRD2/ANKK1 Taq1A Polymorphism (Rs1800497) Has Opposing Effects on D2/3 Receptor Binding in Healthy Controls and Patients with Major Depressive Disorder. Int. J. Neuropsychopharmacol. 2013, 16, 2095–2101. [Google Scholar] [CrossRef] [PubMed]
  36. Spitta, G.; Fliedner, L.E.; Gleich, T.; Zindler, T.; Sebold, M.; Buchert, R.; Heinz, A.; Gallinat, J.; Friedel, E. Association between DRD2/ANKK1 TaqIA Allele Status and Striatal Dopamine D2/3 Receptor Availability in Alcohol Use Disorder. J. Integr. Neurosci. 2022, 21, 171. [Google Scholar] [CrossRef]
  37. Zhang, Y.; Bertolino, A.; Fazio, L.; Blasi, G.; Rampino, A.; Romano, R.; Lee, M.-L.T.; Xiao, T.; Papp, A.; Wang, D.; et al. Polymorphisms in Human Dopamine D2 Receptor Gene Affect Gene Expression, Splicing, and Neuronal Activity during Working Memory. Proc. Natl. Acad. Sci. USA 2007, 104, 20552–20557. [Google Scholar] [CrossRef]
  38. Colizzi, M.; Iyegbe, C.; Powell, J.; Ursini, G.; Porcelli, A.; Bonvino, A.; Taurisano, P.; Romano, R.; Masellis, R.; Blasi, G.; et al. Interaction Between Functional Genetic Variation of DRD2 and Cannabis Use on Risk of Psychosis. Schizophr. Bull. 2015, 41, 1171–1182. [Google Scholar] [CrossRef] [PubMed]
  39. Huminska-Lisowska, K.; Stronska-Pluta, A.; Suchanecka, A.; Massidda, M.; Trybek, G.; Calo, C.M.; Rzeszutko, A.; Reclaw, R.; Grzywacz, A. Association Study of the Taq1D Rs1800498 Polymorphism of the DRD2 Gene with Personality Traits in a Group of Athletes. Balt. J. Health Phys. Act. 2024, 16, Article9. [Google Scholar] [CrossRef]
  40. Sweitzer, M.M.; Halder, I.; Flory, J.D.; Craig, A.E.; Gianaros, P.J.; Ferrell, R.E.; Manuck, S.B. Polymorphic Variation in the Dopamine D4 Receptor Predicts Delay Discounting as a Function of Childhood Socioeconomic Status: Evidence for Differential Susceptibility. Soc. Cogn. Affect. Neurosci. 2013, 8, 499–508. [Google Scholar] [CrossRef]
  41. Dmitrieva, J.; Chen, C.; Greenberger, E.; Ogunseitan, O.; Ding, Y.-C. Gender-Specific Expression of the DRD4 Gene on Adolescent Delinquency, Anger and Thrill Seeking. Soc. Cogn. Affect. Neurosci. 2011, 6, 82–89. [Google Scholar] [CrossRef]
  42. Turic, D. DRD4 And DAT1 in ADHD: Functional Neurobiology to Pharmacogenetics. Pharmacogenom. Pers. Med. 2010, 3, 61–78. [Google Scholar] [CrossRef]
  43. Bakermans-Kranenburg, M.J.; Van IJzendoorn, M.H. Gene-Environment Interaction of the Dopamine D4 Receptor (DRD4) and Observed Maternal Insensitivity Predicting Externalizing Behavior in Preschoolers. Dev. Psychobiol. 2006, 48, 406–409. [Google Scholar] [CrossRef]
  44. Nobile, M.; Giorda, R.; Marino, C.; Carlet, O.; Pastore, V.; Vanzin, L.; Bellina, M.; Molteni, M.; Battaglia, M. Socioeconomic Status Mediates the Genetic Contribution of the Dopamine Receptor D4 and Serotonin Transporter Linked Promoter Region Repeat Polymorphisms to Externalization in Preadolescence. Dev. Psychopathol. 2007, 19, 1147–1160. [Google Scholar] [CrossRef] [PubMed]
  45. Tei, S.; Mitsuhashi, H.; Ishiura, S. Data Describing the Effect of DRD4 Promoter Polymorphisms on Promoter Activity. Data Brief 2016, 7, 1112–1117. [Google Scholar] [CrossRef] [PubMed]
  46. Eichhammer, P.; Sand, P.G.; Stoertebecker, P.; Langguth, B.; Zowe, M.; Hajak, G. Variation at the DRD4 Promoter Modulates Extraversion in Caucasians. Mol. Psychiatry 2005, 10, 520–522. [Google Scholar] [CrossRef] [PubMed]
  47. Michałowska-Sawczyn, M.; Niewczas, M.; Król, P.; Czarny, W.; Rzeszutko, A.; Chmielowiec, K.; Chmielowiec, J.; Grzywacz, A.; Humińska-Lisowska, K.; Lachowicz, M.; et al. Associations Between the Dopamine D4 Receptor Gene Polymorphisms and Personality Traits in Elite Athletes. Biol. Sport 2019, 36, 365–372. [Google Scholar] [CrossRef]
  48. Vereczkei, A.; Demetrovics, Z.; Szekely, A.; Sarkozy, P.; Antal, P.; Szilagyi, A.; Sasvari-Szekely, M.; Barta, C. Multivariate Analysis of Dopaminergic Gene Variants as Risk Factors of Heroin Dependence. PLoS ONE 2013, 8, e66592. [Google Scholar] [CrossRef]
  49. Pan, Y.; Wang, B.; Yao, J. Association of Dopamine D1 Receptor Gene Polymorphism with Schizophrenia: A Meta-Analysis. Neuropsychiatr. Dis. Treat. 2014, 10, 1133–1139. [Google Scholar] [CrossRef]
  50. Abi-Dargham, A.; Mawlawi, O.; Lombardo, I.; Gil, R.; Martinez, D.; Huang, Y.; Hwang, D.-R.; Keilp, J.; Kochan, L.; Van Heertum, R.; et al. Prefrontal Dopamine D1 Receptors and Working Memory in Schizophrenia. J. Neurosci. 2002, 22, 3708–3719. [Google Scholar] [CrossRef]
  51. Park, S.; Kwon, J.; Ahn, C.; Cho, H.-S.; Moon, H.Y.; Lee, C.G. The Role of Dopamine Receptor D2 in Bridging the Intention-Behavior Gap in Sport Participation. Int. J. Environ. Res. Public Health 2021, 18, 2379. [Google Scholar] [CrossRef]
  52. Zhang, K.; Wang, L.; Cao, C.; Li, G.; Fang, R.; Liu, P.; Luo, S.; Zhang, X.; Liberzon, I. A DRD2/ANNK1–COMT Interaction, Consisting of Functional Variants, Confers Risk of Post-Traumatic Stress Disorder in Traumatized Chinese. Front. Psychiatry 2018, 9, 170. [Google Scholar] [CrossRef]
  53. Jiang, Y.; Liu, B.; Wu, C.; Gao, X.; Lu, Y.; Lian, Y.; Liu, J. Dopamine Receptor D2 Gene (DRD2) Polymorphisms, Job Stress, and Their Interaction on Sleep Dysfunction. Int. J. Environ. Res. Public Health 2020, 17, 8174. [Google Scholar] [CrossRef] [PubMed]
  54. Deng, Y.; Huang, J.; Zhang, H.; Zhu, X.; Gong, Q. Association of Expression of DRD2 Rs1800497 Polymorphism with Migraine Risk in Han Chinese Individuals. J. Pain Res. 2018, 11, 763–769. [Google Scholar] [CrossRef] [PubMed]
  55. Zhang, C.; Zhang, J.; Fan, J.; Cheng, W.; Du, Y.; Yu, S.; Fang, Y. Identification of ANKK1 Rs1800497 Variant in Schizophrenia: New Data and Meta-analysis. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2014, 165, 564–571. [Google Scholar] [CrossRef]
  56. Miura, I.; Zhang, J.-P.; Hagi, K.; Lencz, T.; Kane, J.M.; Yabe, H.; Malhotra, A.K.; Correll, C.U. Variants in the DRD2 Locus and Antipsychotic-Related Prolactin Levels: A Meta-Analysis. Psychoneuroendocrinology 2016, 72, 1–10. [Google Scholar] [CrossRef]
  57. Chiang, T.-I.; Lane, H.-Y.; Lin, C.-H. D2 Dopamine Receptor Gene (DRD2) Taq1A (Rs1800497) Affects Bone Density. Sci. Rep. 2020, 10, 13236. [Google Scholar] [CrossRef]
  58. Cohen, O.S.; Weickert, T.W.; Hess, J.L.; Paish, L.M.; McCoy, S.Y.; Rothmond, D.A.; Galletly, C.; Liu, D.; Weinberg, D.D.; Huang, X.-F.; et al. A Splicing-Regulatory Polymorphism in DRD2 Disrupts ZRANB2 Binding, Impairs Cognitive Functioning and Increases Risk for Schizophrenia in Six Han Chinese Samples. Mol. Psychiatry 2016, 21, 975–982. [Google Scholar] [CrossRef]
  59. Moyer, R.A.; Wang, D.; Papp, A.C.; Smith, R.M.; Duque, L.; Mash, D.C.; Sadee, W. Intronic Polymorphisms Affecting Alternative Splicing of Human Dopamine D2 Receptor Are Associated with Cocaine Abuse. Neuropsychopharmacology 2011, 36, 753–762. [Google Scholar] [CrossRef]
  60. Roussotte, F.F.; Jahanshad, N.; Hibar, D.P.; Thompson, P.M. Altered Regional Brain Volumes in Elderly Carriers of a Risk Variant for Drug Abuse in the Dopamine D2 Receptor Gene (DRD2). Brain Imaging Behav. 2015, 9, 213–222. [Google Scholar] [CrossRef]
  61. Smith, C.T.; Dang, L.C.; Buckholtz, J.W.; Tetreault, A.M.; Cowan, R.L.; Kessler, R.M.; Zald, D.H. The Impact of Common Dopamine D2 Receptor Gene Polymorphisms on D2/3 Receptor Availability: C957T as a Key Determinant in Putamen and Ventral Striatum. Transl. Psychiatry 2017, 7, e1091. [Google Scholar] [CrossRef] [PubMed]
  62. Ramsay, H.; Barnett, J.H.; Miettunen, J.; Mukkala, S.; Mäki, P.; Liuhanen, J.; Murray, G.K.; Jarvelin, M.-R.; Ollila, H.; Paunio, T.; et al. Association between Dopamine Receptor D2 (DRD2) Variations Rs6277 and Rs1800497 and Cognitive Performance According to Risk Type for Psychosis: A Nested Case Control Study in a Finnish Population Sample. PLoS ONE 2015, 10, e0127602. [Google Scholar] [CrossRef]
  63. He, H.; Wu, H.; Yang, L.; Gao, F.; Fan, Y.; Feng, J.; Ma, X.-C. Associations between Dopamine D2 Receptor Gene Polymorphisms and Schizophrenia Risk: A PRISMA Compliant Meta-Analysis. Neuropsychiatr. Dis. Treat. 2016, 12, 3129–3144. [Google Scholar] [CrossRef] [PubMed]
  64. Paderina, D.Z.; Boiko, A.S.; Pozhidaev, I.V.; Mednova, I.A.; Goncharova, A.A.; Bocharova, A.V.; Fedorenko, O.Y.; Kornetova, E.G.; Semke, A.V.; Bokhan, N.A.; et al. The Gender-Specific Association of DRD2 Polymorphism with Metabolic Syndrome in Patients with Schizophrenia. Genes 2022, 13, 1312. [Google Scholar] [CrossRef]
  65. Qi, X.; Xuan, J.; Xing, J.; Wang, B.; Yao, J. No Association between Dopamine D3 Receptor Gene Ser9Gly Polymorphism (Rs6280) and Risk of Schizophrenia: An Updated Meta-Analysis. Neuropsychiatr. Dis. Treat. 2017, 13, 2855–2865. [Google Scholar] [CrossRef]
  66. Tsai, H.; North, K.E.; West, S.L.; Poole, C. The DRD3 Rs6280 Polymorphism and Prevalence of Tardive Dyskinesia: A Meta-analysis. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010, 153B, 57–66. [Google Scholar] [CrossRef]
  67. Siokas, V.; Aloizou, A.-M.; Tsouris, Z.; Liampas, I.; Aslanidou, P.; Dastamani, M.; Brotis, A.G.; Bogdanos, D.P.; Hadjigeorgiou, G.M.; Dardiotis, E. Genetic Risk Factors for Essential Tremor: A Review. Tremor Other Hyperkinetic Mov. 2020, 10, 4. [Google Scholar] [CrossRef]
  68. Lowe, N.; Kirley, A.; Hawi, Z.; Sham, P.; Wickham, H.; Kratochvil, C.J.; Smith, S.D.; Lee, S.Y.; Levy, F.; Kent, L.; et al. Joint Analysis of the DRD5 Marker Concludes Association with Attention-Deficit/Hyperactivity Disorder Confined to the Predominantly Inattentive and Combined Subtypes. Am. J. Hum. Genet. 2004, 74, 348–356. [Google Scholar] [CrossRef]
  69. Lachman, H.M.; Papolos, D.F.; Saito, T.; Yu, Y.-M.; Szumlanski, C.L.; Weinshilboum, R.M. Human Catechol-O-Methyltransferase Pharmacogenetics: Description of a Functional Polymorphism and Its Potential Application to Neuropsychiatric Disorders. Pharmacogenetics 1996, 6, 243–250. [Google Scholar] [CrossRef] [PubMed]
  70. Reith, M.E.A.; Kortagere, S.; Wiers, C.E.; Sun, H.; Kurian, M.A.; Galli, A.; Volkow, N.D.; Lin, Z. The Dopamine Transporter Gene SLC6A3: Multidisease Risks. Mol. Psychiatry 2022, 27, 1031–1046. [Google Scholar] [CrossRef] [PubMed]
  71. Bademci, G.; Vance, J.M.; Wang, L. Tyrosine Hydroxylase Gene: Another Piece of the Genetic Puzzle of Parkinson’s Disease. CNS Neurol. Disord. Drug Targets 2012, 11, 469–481. [Google Scholar] [CrossRef]
  72. Tunbridge, E.M.; Harrison, P.J.; Weinberger, D.R. Catechol-o-Methyltransferase, Cognition, and Psychosis: Val158Met and Beyond. Biol. Psychiatry 2006, 60, 141–151. [Google Scholar] [CrossRef]
  73. Lotta, T.; Vidgren, J.; Tilgmann, C.; Ulmanen, I.; Melen, K.; Julkunen, I.; Taskinen, J. Kinetics of Human Soluble and Membrane-Bound Catechol O-Methyltransferase: A Revised Mechanism and Description of the Thermolabile Variant of the Enzyme. Biochemistry 1995, 34, 4202–4210. [Google Scholar] [CrossRef]
  74. Gibbs, A.; Bautista, C.; Mowlem, F.; Naudts, K.; Duka, D. Catechol-O-Methyltransferase Val158met Genotype Determines Effect of Reboxetine on Emotional Memory in Healthy Male Volunteers. J. Psychiatry Neurosci. 2014, 39, E24–E31. [Google Scholar] [CrossRef]
  75. Humińska-Lisowska, K.; Chmielowiec, K.; Chmielowiec, J.; Strońska-Pluta, A.; Bojarczuk, A.; Dzitkowska-Zabielska, M.; Łubkowska, B.; Spieszny, M.; Surała, O.; Grzywacz, A. Association Between the Rs4680 Polymorphism of the COMT Gene and Personality Traits among Combat Sports Athletes. J. Hum. Kinet. 2023, 89, 89–99. [Google Scholar] [CrossRef]
  76. Faraone, S.V.; Spencer, T.J.; Madras, B.K.; Zhang-James, Y.; Biederman, J. Functional Effects of Dopamine Transporter Gene Genotypes on in Vivo Dopamine Transporter Functioning: A Meta-Analysis. Mol. Psychiatry 2014, 19, 880–889. [Google Scholar] [CrossRef]
  77. Congdon, E.; Canli, T. A Neurogenetic Approach to Impulsivity. J. Pers. 2008, 76, 1447–1484. [Google Scholar] [CrossRef]
  78. Horiguchi, M.; Ohi, K.; Hashimoto, R.; Hao, Q.; Yasuda, Y.; Yamamori, H.; Fujimoto, M.; Umeda-Yano, S.; Takeda, M.; Ichinose, H. Functional Polymorphism (C-824T) of the Tyrosine Hydroxylase Gene Affects IQ in Schizophrenia. Psychiatry Clin. Neurosci. 2014, 68, 456–462. [Google Scholar] [CrossRef] [PubMed]
  79. Sadahiro, R.; Suzuki, A.; Shibuya, N.; Kamata, M.; Matsumoto, Y.; Goto, K.; Otani, K. Association Study between a Functional Polymorphism of Tyrosine Hydroxylase Gene Promoter and Personality Traits in Healthy Subjects. Behav. Brain Res. 2010, 208, 209–212. [Google Scholar] [CrossRef] [PubMed]
  80. Zhang, L.; Rao, F.; Wessel, J.; Kennedy, B.P.; Rana, B.K.; Taupenot, L.; Lillie, E.O.; Cockburn, M.; Schork, N.J.; Ziegler, M.G.; et al. Functional Allelic Heterogeneity and Pleiotropy of a Repeat Polymorphism in Tyrosine Hydroxylase: Prediction of Catecholamines and Response to Stress in Twins. Physiol. Genom. 2004, 19, 277–291. [Google Scholar] [CrossRef] [PubMed]
  81. Schlüter, C.; Arning, L.; Fraenz, C.; Friedrich, P.; Pinnow, M.; Güntürkün, O.; Beste, C.; Ocklenburg, S.; Genc, E. Genetic Variation in Dopamine Availability Modulates the Self-Reported Level of Action Control in a Sex-Dependent Manner. Soc. Cogn. Affect. Neurosci. 2019, 14, 759–768. [Google Scholar] [CrossRef]
  82. Zhang, K.; Zhang, L.; Rao, F.; Brar, B.; Rodriguez-Flores, J.L.; Taupenot, L.; O’Connor, D.T. Human Tyrosine Hydroxylase Natural Genetic Variation: Delineation of Functional Transcriptional Control Motifs Disrupted in the Proximal Promoter. Circ. Cardiovasc. Genet. 2010, 3, 187–198. [Google Scholar] [CrossRef]
  83. Wyner, N.; Barash, M.; McNevin, D. Forensic Autosomal Short Tandem Repeats and Their Potential Association with Phenotype. Front. Genet. 2020, 11, 884. [Google Scholar] [CrossRef] [PubMed]
  84. Hill, M.; Anney, R.J.L.; Gill, M.; Hawi, Z. Functional Analysis of Intron 8 and 3′ UTR Variable Number of Tandem Repeats of SLC6A3: Differential Activity of Intron 8 Variants. Pharmacogenom. J. 2010, 10, 442–447. [Google Scholar] [CrossRef]
  85. Pinsonneault, J.K.; Han, D.D.; Burdick, K.E.; Kataki, M.; Bertolino, A.; Malhotra, A.K.; Gu, H.H.; Sadee, W. Dopamine Transporter Gene Variant Affecting Expression in Human Brain Is Associated with Bipolar Disorder. Neuropsychopharmacology 2011, 36, 1644–1655. [Google Scholar] [CrossRef] [PubMed]
  86. Brookes, K.-J.; Mill, J.; Guindalini, C.; Curran, S.; Xu, X.; Knight, J.; Chen, C.-K.; Huang, Y.-S.; Sethna, V.; Taylor, E.; et al. A Common Haplotype of the Dopamine Transporter Gene Associated with Attention-Deficit/Hyperactivity Disorder and Interacting with Maternal Use of Alcohol During Pregnancy. Arch. Gen. Psychiatry 2006, 63, 74–81. [Google Scholar] [CrossRef]
  87. Mill, J.; Asherson, P.; Browes, C.; D’Souza, U.; Craig, I. Expression of the Dopamine Transporter Gene Is Regulated by the 3′ UTR VNTR: Evidence from Brain and Lymphocytes Using Quantitative RT-PCR. Am. J. Med. Genet. 2002, 114, 975–979. [Google Scholar] [CrossRef]
  88. Ishiguro, H.; Arinami, T. Systematic Search for Variations in the Tyrosine Hydroxylase Gene and Their Associations with Schizophrenia, Affective Disorders, and Alcoholism. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 1998, 81, 388–396. [Google Scholar] [CrossRef]
  89. Say, Y.-H. The Association of Insertions/Deletions (INDELs) and Variable Number Tandem Repeats (VNTRs) with Obesity and Its Related Traits and Complications. J. Physiol. Anthropol. 2017, 36, 25. [Google Scholar] [CrossRef] [PubMed]
  90. Albanese, V. Quantitative Effects on Gene Silencing by Allelic Variation at a Tetranucleotide Microsatellite. Hum. Mol. Genet. 2001, 10, 1785–1792. [Google Scholar] [CrossRef]
  91. Doll, B.B.; Hutchison, K.E.; Frank, M.J. Dopaminergic Genes Predict Individual Differences in Susceptibility to Confirmation Bias. J. Neurosci. 2011, 31, 6188–6198. [Google Scholar] [CrossRef]
  92. Dimauro, I.; Paronetto, M.P.; Caporossi, D. Exercise, Redox Homeostasis and the Epigenetic Landscape. Redox Biol. 2020, 35, 101477. [Google Scholar] [CrossRef] [PubMed]
  93. Sellami, M.; Bragazzi, N.; Prince, M.S.; Denham, J.; Elrayess, M. Regular, Intense Exercise Training as a Healthy Aging Lifestyle Strategy: Preventing DNA Damage, Telomere Shortening and Adverse DNA Methylation Changes Over a Lifetime. Front. Genet. 2021, 12, 652497. [Google Scholar] [CrossRef]
  94. Bukowska-Damska, A.; Reszka, E.; Kaluzny, P.; Wieczorek, E.; Przybek, M.; Zienolddiny, S.; Peplonska, B. Sleep Quality and Methylation Status of Selected Tumor Suppressor Genes among Nurses and Midwives. Chronobiol. Int. 2018, 35, 122–131. [Google Scholar] [CrossRef]
  95. Etayo-Urtasun, P.; Sáez De Asteasu, M.L.; Izquierdo, M. Effects of Exercise on DNA Methylation: A Systematic Review of Randomized Controlled Trials. Sports Med. 2024, 54, 2059–2069. [Google Scholar] [CrossRef]
  96. Ursini, G.; Bollati, V.; Fazio, L.; Porcelli, A.; Iacovelli, L.; Catalani, A.; Sinibaldi, L.; Gelao, B.; Romano, R.; Rampino, A.; et al. Stress-Related Methylation of the Catechol-O-Methyltransferase Val158 Allele Predicts Human Prefrontal Cognition and Activity. J. Neurosci. 2011, 31, 6692–6698. [Google Scholar] [CrossRef]
  97. Humińska-Lisowska, K.; Chmielowiec, K.; Strońska-Pluta, A.; Chmielowiec, J.; Suchanecka, A.; Masiak, J.; Michałowska-Sawczyn, M.; Boroń, A.; Cięszczyk, P.; Grzywacz, A. Epigenetic Analysis of the Dopamine Transporter Gene DAT1 with a Focus on Personality Traits in Athletes. Int. J. Mol. Sci. 2023, 24, 8931. [Google Scholar] [CrossRef]
  98. Recław, R.; Chmielowiec, J.; Chmielowiec, K.; Larysz, D.; Pedrycz, A.; Grzywacz, A. Interaction Between the VNTR of the DAT1 Gene and DAT1 Methylation in Relation to Impulsivity in Combat Sports Athletes. Biomedicines 2025, 13, 2893. [Google Scholar] [CrossRef] [PubMed]
  99. Schmitz, J.; Kumsta, R.; Moser, D.; Güntürkün, O.; Ocklenburg, S. DNA Methylation of Dopamine-Related Gene Promoters Is Associated with Line Bisection Deviation in Healthy Adults. Sci. Rep. 2019, 9, 5902. [Google Scholar] [CrossRef] [PubMed]
  100. Pedraza-Ramirez, I.; Musculus, L.; Raab, M.; Laborde, S. Setting the Scientific Stage for Esports Psychology: A Systematic Review. Int. Rev. Sport Exerc. Psychol. 2020, 13, 319–352. [Google Scholar] [CrossRef]
  101. Ayranci, M.; Aydin, M.K. The Complex Interplay between Psychological Factors and Sports Performance: A Systematic Review and Meta-Analysis. PLoS ONE 2025, 20, e0330862. [Google Scholar] [CrossRef]
  102. Matuszewski, P.; Dobrowolski, P.; Zawadzki, B. The Association Between Personality Traits and eSports Performance. Front. Psychol. 2020, 11, 1490. [Google Scholar] [CrossRef] [PubMed]
  103. Behnke, M.; Stefanczyk, M.M.; Żurek, G.; Sorokowski, P. Esports Players Are Less Extroverted and Conscientious than Athletes. Cyberpsychology Behav. Soc. Netw. 2023, 26, 50–56. [Google Scholar] [CrossRef] [PubMed]
  104. Nieoullon, A.; Coquerel, A. Dopamine: A Key Regulator to Adapt Action, Emotion, Motivation and Cognition. Curr. Opin. Neurol. 2003, 16, S3–S9. [Google Scholar] [CrossRef]
  105. Enge, S.; Sach, M.; Reif, A.; Lesch, K.-P.; Miller, R.; Fleischhauer, M. Cumulative Dopamine Genetic Score Predicts Behavioral and Electrophysiological Correlates of Response Inhibition via Interactions with Task Demand. Cogn. Affect. Behav. Neurosci. 2020, 20, 59–75. [Google Scholar] [CrossRef]
  106. Chmielowiec, K.; Michałowska-Sawczyn, M.; Masiak, J.; Chmielowiec, J.; Trybek, G.; Niewczas, M.; Czarny, W.; Cieszczyk, P.; Massidda, M.; Proia, P.; et al. Analysis of DRD2 Gene Polymorphism in the Context of Personality Traits in a Group of Athletes. Genes 2021, 12, 1219. [Google Scholar] [CrossRef]
  107. Lachowicz, M.; Recław, R.; Chmielowiec, K.; Chmielowiec, J.; Łosińska, K.; Suchanecka, A.; Masiak, J.; Grzywacz, A. Dopaminergic Modulation of Conscientiousness: DRD2 Rs1799732 and Personality Traits in Elite Mixed Martial Arts Athletes. Genes 2025, 16, 720. [Google Scholar] [CrossRef]
  108. Kim, E.; Lee, D.; Do, K.; Kim, J. Interaction Effects of DRD2 Genetic Polymorphism and Interpersonal Stress on Problematic Gaming in College Students. Genes 2022, 13, 449. [Google Scholar] [CrossRef]
  109. Noble, E.P.; Jeor, S.T.S.; Ritchie, T.; Syndulko, K.; Jeor, S.C.S.; Fitch, R.J.; Brunner, R.L.; Sparkes, R.S. D2 Dopamine Receptor Gene and Cigarette Smoking: A Reward Gene? Med. Hypotheses 1994, 42, 257–260. [Google Scholar] [CrossRef] [PubMed]
  110. McAuley, A.B.T.; Hughes, D.C.; Tsaprouni, L.G.; Varley, I.; Suraci, B.; Baker, J.; Herbert, A.J.; Kelly, A.L. Genetic Associations with Personality and Mental Toughness Profiles of English Academy Football Players: An Exploratory Study. Psychol. Sport Exerc. 2022, 61, 102209. [Google Scholar] [CrossRef]
  111. Dohrn, I.-M.; Papenberg, G.; Winkler, E.; Welmer, A.-K. Impact of Dopamine-Related Genetic Variants on Physical Activity in Old Age—A Cohort Study. Int. J. Behav. Nutr. Phys. Act. 2020, 17, 68. [Google Scholar] [CrossRef]
  112. Gerra, M.C.; Dallabona, C.; Manfredini, M.; Giordano, R.; Capriotti, C.; González-Villar, A.; Triñanes, Y.; Arendt-Nielsen, L.; Carrillo-de-la-Peña, M.T. The Polymorphism Val158Met in the COMT Gene: Disrupted Dopamine System in Fibromyalgia Patients? Pain 2024, 165, e184–e189. [Google Scholar] [CrossRef]
  113. Valeeva, E.V.; Kashevarov, G.S.; Kasimova, R.R.; Ahmetov, I.I.; Kravtsova, O.A. Association of the Val158Met Polymorphism of the COMT Gene with Measures of Psychophysiological Status in Athletes. Neurosci. Behav. Physiol. 2020, 50, 485–492. [Google Scholar] [CrossRef]
  114. Huppertz, C.; Bartels, M.; Groen-Blokhuis, M.M.; Dolan, C.V.; De Moor, M.H.M.; Abdellaoui, A.; Van Beijsterveldt, C.E.M.; Ehli, E.A.; Hottenga, J.-J.; Willemsen, G.; et al. The Dopaminergic Reward System and Leisure Time Exercise Behavior: A Candidate Allele Study. BioMed Res. Int. 2014, 2014, 591717. [Google Scholar] [CrossRef]
  115. Benoit, J.J.; Roudaia, E.; Johnson, T.; Love, T.; Faubert, J. The Neuropsychological Profile of Professional Action Video Game Players. PeerJ 2020, 8, e10211. [Google Scholar] [CrossRef] [PubMed]
  116. Niewczas, M.; Grzywacz, A.; Leźnicka, K.; Chmielowiec, K.; Chmielowiec, J.; Maciejewska-Skrendo, A.; Ruzbarsky, P.; Masiak, J.; Czarny, W.; Cięszczyk, P. Association between Polymorphism Rs1799732 of DRD2 Dopamine Receptor Gene and Personality Traits among MMA Athletes. Genes 2021, 12, 1217. [Google Scholar] [CrossRef]
  117. Michałowska-Sawczyn, M.; Humińska-Lisowska, K.; Chmielowiec, K.; Chmielowiec, J.; Strońska-Pluta, A.; Suchanecka, A.; Zadroga, Ł.; Massidda, M.; Calò, C.M.; Recław, R.; et al. Association Analysis of the Dopaminergic Receptor 2 Gene Tag1Brs1079597 and Personality Traits among a Cohort of Professionalathletes. Biol. Sport 2025, 42, 35–43. [Google Scholar] [CrossRef]
  118. Thomson, C.J. The Genetics of Sports Behaviour: The Role of the DRD4 Gene in Sensation Seeking in Skiers. Ph.D. Thesis, University of British Columbia, Vancouver, BC, Canada, 2008. [Google Scholar] [CrossRef]
  119. Bayraktar, I.; Cepicka, L.; Barasinska, M.; Kazan, H.H.; Zorba, E.; Ergun, M.A.; Eken, Ö.; Ceylan, H.İ.; Bulgay, C.; Gabrys, T. Athletic Performance, Sports Experience, and Exercise Addiction: An Association Study on ANKK1 Gene Polymorphism Rs1800497. Front. Psychol. 2023, 14, 1182575. [Google Scholar] [CrossRef] [PubMed]
  120. Thomson, C.J.; Hanna, C.W.; Carlson, S.R.; Rupert, J.L. The −521 C/T Variant in the Dopamine-4-receptor Gene (DRD4) Is Associated with Skiing and Snowboarding Behavior. Scand. J. Med. Sci. Sports 2013, 23, e108–e113. [Google Scholar] [CrossRef]
  121. Abrahams, S.; McFie, S.; Lacerda, M.; Patricios, J.; Suter, J.; September, A.V.; Posthumus, M. Unravelling the Interaction between the DRD2 and DRD4 Genes, Personality Traits and Concussion Risk. BMJ Open Sport Exerc. Med. 2019, 5, e000465. [Google Scholar] [CrossRef]
  122. Van Der Mee, D.J.; Fedko, I.O.; Hottenga, J.-J.; Ehli, E.A.; Van Der Zee, M.D.; Ligthart, L.; Van Beijsterveldt, T.C.E.M.; Davies, G.E.; Bartels, M.; Landers, J.G.; et al. Dopaminergic Genetic Variants and Voluntary Externally Paced Exercise Behavior. Med. Sci. Sports Exerc. 2018, 50, 700–708. [Google Scholar] [CrossRef] [PubMed]
  123. Michałowska-Sawczyn, M.; Lachowicz, M.; Grzywacz, A.; Suchanecka, A.; Chmielowiec, J.; Chmielowiec, K.; Chycki, J.; Trybek, G.; Żmijewski, P.; Cięszczyk, P. Analysis of Polymorphic Variants of the Dopamine Transporter (DAT1) Gene Polymorphism and Personality Traits Among Athletes. J. Hum. Kinet. 2020, 72, 79–89. [Google Scholar] [CrossRef]
  124. London, E.D. Human Brain Imaging Links Dopaminergic Systems to Impulsivity. In Recent Advances in Research on Impulsivity and Impulsive Behaviors; De Wit, H., Jentsch, J.D., Eds.; Current Topics in Behavioral Neurosciences; Springer International Publishing: Cham, Switzerland, 2020; Volume 47, pp. 53–71. [Google Scholar]
  125. Trofimova, I.; Robbins, T.W.; Sulis, W.H.; Uher, J. Taxonomies of Psychological Individual Differences: Biological Perspectives on Millennia-Long Challenges. Philos. Trans. R. Soc. B Biol. Sci. 2018, 373, 20170152. [Google Scholar] [CrossRef]
  126. Kim, J.; Choe, Y.; Cumming, P.; Son, Y.; Kim, H.; Joo, Y.; Kim, J. Relationship of Self-transcendence Traits with in Vivo Dopamine D2/3 Receptor Availability and Functional Connectivity: An [18F]Fallypride PET and fMRI Study. Synapse 2019, 73, e22121. [Google Scholar] [CrossRef]
  127. Dahoun, T.; Pardiñas, A.F.; Veronese, M.; Bloomfield, M.A.P.; Jauhar, S.; Bonoldi, I.; Froudist-Walsh, S.; Nosarti, C.; Korth, C.; Hennah, W.; et al. The Effect of the DISC1 Ser704Cys Polymorphism on Striatal Dopamine Synthesis Capacity: An [18F]-DOPA PET Study. Hum. Mol. Genet. 2018, 27, 3498–3506. [Google Scholar] [CrossRef]
  128. Enge, S.; Fleischhauer, M.; Lesch, K.-P.; Strobel, A. On the Role of Serotonin and Effort in Voluntary Attention: Evidence of Genetic Variation in N1 Modulation. Behav. Brain Res. 2011, 216, 122–128. [Google Scholar] [CrossRef]
  129. Plaza-Diaz, J.; Izquierdo, D.; Torres-Martos, Á.; Baig, A.T.; Aguilera, C.M.; Ruiz-Ojeda, F.J. Impact of Physical Activity and Exercise on the Epigenome in Skeletal Muscle and Effects on Systemic Metabolism. Biomedicines 2022, 10, 126. [Google Scholar] [CrossRef] [PubMed]
  130. Geiger, C.; Needhamsen, M.; Emanuelsson, E.B.; Norrbom, J.; Steindorf, K.; Sundberg, C.J.; Reitzner, S.M.; Lindholm, M.E. DNA Methylation of Exercise-Responsive Genes Differs between Trained and Untrained Men. BMC Biol. 2024, 22, 147. [Google Scholar] [CrossRef] [PubMed]
  131. Cappelli, K.; Mecocci, S.; Porceddu, A.; Albertini, E.; Giontella, A.; Miglio, A.; Silvestrelli, M.; Verini Supplizi, A.; Marconi, G.; Capomaccio, S. Genome-Wide Epigenetic Modifications in Sports Horses during Training as an Adaptation Phenomenon. Sci. Rep. 2023, 13, 18786. [Google Scholar] [CrossRef] [PubMed]
  132. Brooke, R.T.; Kocher, T.; Zauner, R.; Gordevicius, J.; Milčiūtė, M.; Nowakowski, M.; Haser, C.; Blobel, T.; Sieland, J.; Langhoff, D.; et al. Epigenetic Age Monitoring in Professional Soccer Players for Tracking Recovery and the Effects of Strenuous Exercise. Aging Cell 2025, 24, e70182. [Google Scholar] [CrossRef]
  133. Yan, L.; Wei, J.; Yang, F.; Wang, M.; Wang, S.; Cheng, T.; Liu, X.; Jia, Y.; So, K.; Zhang, L. Physical Exercise Prevented Stress-Induced Anxiety via Improving Brain RNA Methylation. Adv. Sci. 2022, 9, 2105731. [Google Scholar] [CrossRef]
  134. Maier, T.; Alzahabi, R.; Sharpe, B.T.; Maier, H. The React–Predict–Manipulate Model: A Proposed Theoretical Hierarchy of Decision Making in Competitive Environments. J. Electron. Gaming Esports 2024, 2, jege.2024-0014. [Google Scholar] [CrossRef]
  135. Sharpe, B.T.; Birch, P.D.J. Psychology of Esports Special Issue: A Catalyst for Change. J. Electron. Gaming Esports 2024, 2, jege.2024-0058. [Google Scholar] [CrossRef]
  136. Miao, H.; He, H.; Hou, X.; Wang, J.; Chi, L. Cognitive Expertise in Esport Experts: A Three-Level Model Meta-Analysis. PeerJ 2024, 12, e17857. [Google Scholar] [CrossRef] [PubMed]
  137. Valls-Serrano, C.; De Francisco, C.; Caballero-López, E.; Caracuel, A. Cognitive Flexibility and Decision Making Predicts Expertise in the MOBA Esport, League of Legends. Sage Open 2022, 12, 21582440221142728. [Google Scholar] [CrossRef]
  138. Kou, Y.; Gui, X. Emotion Regulation in eSports Gaming: A Qualitative Study of League of Legends. Proc. ACM Hum. Comput. Interact. 2020, 4, 1–25. [Google Scholar] [CrossRef]
  139. Beres, N.A.; Klarkowski, M.; Mandryk, R.L. Playing with Emotions: A Systematic Review Examining Emotions and Emotion Regulation in Esports Performance. Proc. ACM Hum. Comput. Interact. 2023, 7, 558–587. [Google Scholar] [CrossRef]
  140. Matsui, T.; Takahashi, S.; Ochi, G.; Yoshitake, S.; Funabashi, D.; Matsuoka, H.; Kagesawa, J.; Dobashi, S.; Yoshimoto, H.; Sakairi, Y.; et al. Cognitive Decline with Pupil Constriction Independent of Subjective Fatigue during Prolonged Esports across Player Expertise Levels. Comput. Hum. Behav. 2024, 156, 108219. [Google Scholar] [CrossRef]
  141. Garrett, D.D.; Kloosterman, N.A.; Epp, S.; Chopurian, V.; Kosciessa, J.Q.; Waschke, L.; Skowron, A.; Shine, J.M.; Perry, A.; Salami, A.; et al. Dynamic Regulation of Neural Variability during Working Memory Reflects Dopamine, Functional Integration, and Decision-Making. BioRxiv 2022. [Google Scholar] [CrossRef]
  142. Westbrook, A.; Van Den Bosch, R.; Määttä, J.I.; Hofmans, L.; Papadopetraki, D.; Cools, R.; Frank, M.J. Dopamine Promotes Cognitive Effort by Biasing the Benefits versus Costs of Cognitive Work. Science 2020, 367, 1362–1366. [Google Scholar] [CrossRef]
  143. Gong, D.; He, H.; Ma, W.; Liu, D.; Huang, M.; Dong, L.; Gong, J.; Li, J.; Luo, C.; Yao, D. Functional Integration between Salience and Central Executive Networks: A Role for Action Video Game Experience. Neural Plast. 2016, 2016, 9803165. [Google Scholar] [CrossRef]
  144. Zmigrod, L.; Robbins, T.W. Dopamine, Cognitive Flexibility, and IQ: Epistatic Catechol-O-MethylTransferase:DRD2 Gene–Gene Interactions Modulate Mental Rigidity. J. Cogn. Neurosci. 2021, 34, 153–179. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Schematic overview of dopamine D1–D5 receptors: family classification, main signalling pathways, and predominant neuroanatomical localisation.
Figure 1. Schematic overview of dopamine D1–D5 receptors: family classification, main signalling pathways, and predominant neuroanatomical localisation.
Genes 17 00144 g001
Figure 2. Conceptual framework illustrating the relationships between dopaminergic genetic factors (DRD2, DRD4, COMT, DAT1), major dopaminergic pathways, epigenetic mechanisms, environmental influences, and performance-related traits in sports and esports.
Figure 2. Conceptual framework illustrating the relationships between dopaminergic genetic factors (DRD2, DRD4, COMT, DAT1), major dopaminergic pathways, epigenetic mechanisms, environmental influences, and performance-related traits in sports and esports.
Genes 17 00144 g002
Table 1. Characteristics of dopamine receptor families, their mechanisms of action, and location.
Table 1. Characteristics of dopamine receptor families, their mechanisms of action, and location.
ReceptorReceptor GroupNeuroanatomical Location of the
Receptor
Biological
Functions
Biological
Effect
Mechanism of ActionEffect on
Adenylate
Cyclase
DRD1 (D1)D1 (D1-like)Cerebral cortex,
striatum,
hippocampus,
olfactory bulb,
limbic system
Learning,
working memory,
executive
functions,
motivation
Neuron
excitation,
increased
activity
adenylyl
cyclase →
↑ cAMP
↑ cAMP
(stimulation)
DRD2 (D2)D2 (D2-like)Striatum, substantia nigra, thalamus,
hypothalamus,
cortex
Motor
coordination, motivation, sleep, hormonal regulation
Inhibition of neuronal
activity,
inhibitory effect
Inhibits adenylyl cyclase →
↓ cAMP
↓ cAMP
(inhibition or no effect)
DRD3 (D3)D2 (D2-like)Limbic system,
nucleus accumbent, striatum,
hippocampus
Regulation of reward-related behaviour and emotional
responses
Inhibition of neuronal
activity,
inhibitory
effect
Inhibits adenylyl cyclase↓ cAMP
(inhibition or no effect)
DRD4 (D4)D2 (D2-like)Prefrontal cortex, amygdala,
hippocampus,
striatum
Attention,
impulse control, exploratory
behaviour
Inhibition of neuronal activity, inhibitory
effect
Inhibits adenylyl cyclase↓ cAMP (inhibition or no effect)
DRD5 (D5)D1 (D1-like)Frontal cortex,
hippocampus, and cingulate cortex
Cognitive
functions
similar to D1
Neuron
excitation,
increased
activity
Stimulates adenylyl cyclase →
↑ cAMP
↑ cAMP
(stimulation)
Source: own elaboration based on Beaulieu & Gainetdinov [28], and additional review sources [30].
Table 2. Overview of selected DRD1–DRD5 gene polymorphisms: location, mechanism of action, and research context.
Table 2. Overview of selected DRD1–DRD5 gene polymorphisms: location, mechanism of action, and research context.
GenPolymorphismLocation
(Genomic/
Structural)
Biological
Functions
Biological
Effect
Research
DRD1rs4532
(A > G)
5′ UTR/promoter regionA nucleotide change may create short open reading frames that inhibit translation; potential impact on receptor expression.It may modulate the
effects of dopaminergic drugs and executive functions, but there is no clear clinical.
evidence.
[49,50,51]
DRD2rs1800497
(Taq1A, C > T)
Intron of the ANKK1 gene
adjacent to DRD2
The T allele (A1) reduces the density of D2 receptors in the striatum; it affects dopaminergic transmission.Linked to differences in motivation, impulses and addictions, effect dependent on
environmental context.
[34,35,36,52,53,54,55,56,57]
DRD2rs1076560
(G > T)
Intron
(affects splicing)
Allele T reduces the expression of the presynaptic short isoform of the dopamine D2 receptor (D2S), increasing the proportion of postsynaptic long isoform of the dopamine D2 receptor (D2L).Associated with greater activity in the basal ganglia and prefrontal cortex during cognitive tasks, as well as with a higher risk of psychotic disorders.[33,37,38,58,59,60]
DRD2rs6277
(C957T, C > T)
Exon 7
(Synonymous
polymorphism)
The T allele reduces mRNA stability but increases the availability of D2/3 receptors in the striatum.Reduces the risk of schizophrenia in the European population, may affect working memory and learning through reinforcement.[61,62,63]
DRD2rs1799732
(-141C Ins/Del)
Promoter
(Sp1 binding site)
The deletion reduces promoter activity in luciferase assays; it may alter receptor expression.Variable effect on body weight and the action of neuroleptic drugs; stronger effect in women[63,64]
DRD3rs6280
(Ser9Gly, A > G)
Exon 1 The Gly allele increases the affinity of the D3 receptor for dopamine and enhances intracellular signalling.May modulate response to reward and dopaminergic drugs, no clear effect on
Schizophrenia.
[35,65,66,67]
DRD4VNTR 48 bp (2R/4R/7R)Exon 3
(tandem repeats)
Allele 7R reduces adenylate cyclase inhibition and dopamine sensitivity.Increased impulsivity, novelty seeking; the effect depends on the environment and
upbringing.
[40,43,44]
DRD4rs1800955
(–521 C > T)
Promoter region (5′)May affect promoter activity in neurons (no clear results)Variability in personality traits (extroversion, impulsivity); effect dependent on gender and environment.[45,46,48]
DRD5(CA)
microsatellite
(148 bp)
Approximately 18 kb above the geneIt does not encode a protein but may be coupled with another regulatory variant.A slight increase in the risk of Attention Deficit Hyperactivity Disorder (ADHD) (OR ≈ 1.24)—mainly in the inattentive and combined subtypes.[68]
Source: own work based on Beaulieu & Gainetdinov, Gluskin & Mickey [28,34].
Table 3. Polymorphisms of COMT, SLC6A3, and TH genes: location, biological and functional activity.
Table 3. Polymorphisms of COMT, SLC6A3, and TH genes: location, biological and functional activity.
GenPolymorphismLocation
(Genomic/
Structural)
Biological
Functions
Biological
Effect
Research
COMTrs4680 (Val158Met,
G > A)
Exon 4; chromosome 22q11.21Substitution of valine for methionine (Val→Met) reduces COMT enzyme activity by approximately 35–40%, increasing.
dopamine availability in the prefrontal cortex.
The Met allele is
associated with better working memory and executive functions, but greater reactivity to stress and emotional disturbances.
[18,20,72,73,74,75,82,83]
COMTrs4633 (C > T)Exon 3; chromosome 22q11.21Synonymous
polymorphism, does not change the amino acid, but affects mRNA
stability and enzyme
expression.
Usually coupled
with rs4680;
affects cognitive and emotional functions in a similar way to Val158Met.
[72]
SLC6A3rs28363170
(3′-UTR VNTR, 40 bp, 9R/10R)
Region 3′-UTR; chromosome 5p15.33The number of repeats modulates gene
expression levels; the 9R allele is associated with lower expression and less DAT, while the 10R allele is associated with higher expression and more
efficient dopamine
uptake.
This variant is
associated with
differences in reward sensitivity, impulsivity, and activity of the basal ganglia and prefrontal cortex in motivational tasks; effects depend on population and
environmental factors.
[70,76,77,84]
SLC6A3rs27072 (A > G)Region 3′ UTR; chromosome 5p15.33The variant affects mRNA stability and
dopamine transporter
expression levels; it may be linked to the 3′-UTR VNTR (rs28363170).
Associated with
differences in attention control and
impulsivity; moderate effects, often
modulated by
environmental factors.
[85,86,87]
THrs10770141
(C > T)
Promoter; chromosome 11p15.5Allele T increases
promoter activity and TH transcription, increasing dopamine synthesis.
May increase
susceptibility to stress and the risk of
depression or
schizophrenia; effect dependent on
environment.
[82,88]
THrs6356
C-824T
Promoter; chromosome 11p15.5The C > T change affects the binding of
transcription factors and the mRNA level of the
enzyme.
Combined with
differences in
temperament and
cognitive functions in people with mental
disorders.
[79,83,88,89,90]
Table 4. Functional characteristics of polymorphisms in DRD1, DRD2, DRD3, DRD4, COMT, SLC6A3, and TH genes and their potential relevance to cognitive traits and esports performance.
Table 4. Functional characteristics of polymorphisms in DRD1, DRD2, DRD3, DRD4, COMT, SLC6A3, and TH genes and their potential relevance to cognitive traits and esports performance.
GenPolymorphism
(Variant)
LocationFunctional EffectPopulation and
Research Results
Potential Impact on Characteristics in
Esports
DRD2rs1799732
(–141C Ins/Del)
Promoter 5′The deletion reduces
promoter activity and the number of D2 receptors.
Polish MMA fighters
(n = 85) vs. controls
(n = 284). The deletion was associated with lower reward
dependence and less harm avoidance [106,116]
Lower reward
dependence may
promote independence and perseverance in stressful situations; the player may continue playing despite the lack of immediate rewards.
DRD2rs1800498
(Taq1D, C/T)
Intron 1It is believed that the T allele reduces the density of D2 receptors.Polish athletes (n = 159) vs. control group
(n = 232). Taq1D (C/T) was associated with higher conscientiousness in athletes [39]
May favour planning,
discipline and strategic organization; beneficial for training and in-game strategy.
DRD2rs1079597
(Tag1B, G/A)
Intron 1Allele reduces
receptor expression.
Professional athletes
(n = 163) vs. controls
(n = 232). G/G genotype and G allele were more frequent in athletes;
athletes scored higher on extraversion and
conscientiousness [117]
Variation may shape
extraversion and
conscientiousness,
affecting social
interaction, motivation, and discipline in esports.
DRD2rs6277
(C957T)
Exon 7The T allele reduces mRNA stability and D2 expression.Skiers and snowboarders
(M = 341, F = 258);
Caucasian; C allele
increases D2
expression while T
allele decreases it [118]
Reduced receptor
availability may affect
reward processing and reaction speed; potential influence on focus and motivation, though
unstudied in esports.
DRD2/ANKK1rs1800497
(Taq1A, A1/A2)
ANKK1 gene (close to DRD2)Allele A1 reduces the availability of D2
receptors.
Elite athletes (n = 60) vs.
(n = 20) control group.
Studies indicate the A1 allele is linked to increased impulsivity and risk-taking [119]
May promote risk-taking and reward-seeking
behaviours; could be
advantageous in high-risk gaming
strategies, but evidence in esports is lacking.
DRD3rs167771
(A/G)
IntronThe A/A genotype is
associated with greater agreeableness; G reduces sensation seeking.
Football players carrying A/A genotype showed higher agreeableness compared with carriers of the G allele [110]Enhanced agreeableness may support teamwork and communication;
reduced sensation
seeking could lower risk-taking, potentially leading to more
conservative play.
DRD3rs6280
(Ser9Gly)
Exon 1 (amino acid change)The Gly allele increases receptor affinity.No direct sports studies; functional assays indicate a higher affinity for
dopamine for the Gly variant [114]
Increased receptor
sensitivity may heighten reward responsiveness and motivation;
implications for gaming performance remain speculative.
DRD4VNTR
(Number of
repetitions)
Exon 3Long alleles (≥7 repeats) reduce receptor binding and lower cAMP.Meta-analyses show
carriers of the long allele score higher on
novelty-seeking traits [47,120,121]
Higher novelty seeking may foster exploration and creative strategies, but could also lead to
impulsive risk-taking in esports.
DRD5VNTR
(130–166 bp)
PromoterThe 148 bp allele reduces D5 expression.The 148 bp allele of the microsatellite near DRD5 has been associated with ADHD, but not directly with receptor levels. Association studies indicate the 148 bp allele is linked to ADHD and decreased attention, but there are no
athlete-specific data [122]
Reduced receptor
function may diminish dopaminergic signalling and attention; possible impact on focus and
reward processing in
esports, but the evidence is indirect.
COMTrs4680 (Val158Met, G/A)Exon 4The Met allele reduces COMT activity
(↑dopamine)
Combat sports athletes
(n = 258) vs. controls
(n = 278). Athletes had
different genotype
frequencies and showed significant interactions between the COMT genotype and
personality traits such as novelty seeking, self-management, and self-transcendence [75]
Lower COMT activity (Met allele) elevates
dopamine, which may enhance cognitive
control, stress resilience, and
self-management-traits advantageous for
sustained focus and emotion regulation in
esports.
SLC6A3 (DAT1)VNTR
(9R/10R)
3′UTRThe direction of the effect may depend on the study.Polish male combat sports athletes (n = 200)
Polish male controls
(n = 102); 9/10 VNTR
genotype associated with lower levels of anxiety in CS;
10/10 VNTR genotype
associated with lower agreeability in CS [123]
10R allele carriers may exhibit greater
aggressiveness and
excitability, possibly
favouring assertive play; 9R allele carriers may be more sensitive to reward and punishment,
influencing risk
assessment and
emotional responses in competitive gaming.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Majchrzak, N.; Humińska-Lisowska, K.; Leońska-Duniec, A. Driven by Dopamine: Genetic Insights into Motivation and Performance in Sports and Esports. Genes 2026, 17, 144. https://doi.org/10.3390/genes17020144

AMA Style

Majchrzak N, Humińska-Lisowska K, Leońska-Duniec A. Driven by Dopamine: Genetic Insights into Motivation and Performance in Sports and Esports. Genes. 2026; 17(2):144. https://doi.org/10.3390/genes17020144

Chicago/Turabian Style

Majchrzak, Natalia, Kinga Humińska-Lisowska, and Agata Leońska-Duniec. 2026. "Driven by Dopamine: Genetic Insights into Motivation and Performance in Sports and Esports" Genes 17, no. 2: 144. https://doi.org/10.3390/genes17020144

APA Style

Majchrzak, N., Humińska-Lisowska, K., & Leońska-Duniec, A. (2026). Driven by Dopamine: Genetic Insights into Motivation and Performance in Sports and Esports. Genes, 17(2), 144. https://doi.org/10.3390/genes17020144

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop